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Abstract 
 
In last the decades, advances relevant to the generation of 3D 
Engineered Cardiac Tissues (ECTs) have been made. In reason of this, 
ECTs are now considered a great promise for in vitro studies of cardiac 
development, disease and, eventually, for strategies for the repair of 
the structure and function of the injured myocardium. 
Among the several physical stimuli which have been exploited to 
improve the functionality and maturation of ECTs, a preeminent role 
has been ascribed to mechanical stimulation. Appropriate mechanical 
stimulation can be recreated and maintained within bioreactors, which 
are devices/platforms devoted to mimic the physiological milieu in a 
monitored/controlled culture environment, where the engineered 
constructs can be properly stimulated.  
One main limitation of the bioreactor-based strategy for cardiac 
tissue engineering applications is that the devices which are currently 
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used are meant to passively apply to ECTs a stimulus predefined by 
the user, regardless of their level of maturation along the duration of 
the in vitro culture. 
In this scenario, and trying to overcome current limitations, a novel 
bioreactor design has been conceived for the investigation of 3D ECTs 
with a biomimetic approach. Technically, the here proposed bioreactor 
is capable (1) to apply native-like or pathologic mechanical stimuli 
(cyclic strain) by means of a reliable linear actuator operating in a 
wide range of strains and frequencies, and (2) to monitor in real-time 
both chemo-physical parameters (e.g. oxygen tension, pH) of the milieu 
and the mechanical stiffness of ECTs by means of dedicated sensors, 
eventually adapting the stimulation to the actual stage of maturation 
of the constructs.  
As a proof of concept, a first experimental campaign has been 
carried out with a double aim: (1) to verify the bioreactor feasibility in 
delivering mechanical cyclical stimulation to 3D fibrin-based, ring 
shaped Engineered Cardiac Tissues (ECTs); (2) to assess the effect of 
cyclic strain on tissue maturation, contractility and modification on its 
mechanical properties. 
In detail, the bioreactor platform has been preliminarily tested to 
verify protocols for hold on, sterilization, and control of the delivered 
mechanical stimuli. Firstly, the suitability of the bioreactor platform in 
culturing ad-hoc designed constructs, in terms of ease of use and 
capability in setting the stimulation parameters, has been tested. Then, 
the observed maturation of ring shaped ECTs subject to sinusoidal 
 
iii 
cyclic strain within the bioreactor has confirmed the potency of the 
proposed approach and the instrumental role of mechanical stimulation 
in ECTs maturation and in the development of an adult-like cardiac 
phenotype responsive to electrical excitation.  
Even if further validation steps are required before the 
implementation of culture strategy fully adaptive in terms of 
mechanical stimuli applied to the engineered cardiac constructs, the 
developed bioreactor represents a valuable proof of concept for, in its 
most advanced operational mode, biomimetic culturing of engineered 
cardiac constructs.  
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Chapter 1  
Introduction 
1.1 Clinical motivations and perspectives 
Myocardial infarction (MI) and heart failure are the leading causes of 
mortality all over the world (Roger, et al. 2012). Cardiac function 
deteriorates along with the pathological progression of MI, and in the 
end stage, arrhythmias, mitral regurgitation, and heart failure can occur 
and become fatal (De Celle, et al. 2004, Cleutjens, Blankesteijn and J.F. 
1999). At the state of the art, when we are in presence of a failing heart, 
the only effective therapy is still heart transplantation, which is limited 
by low supply of matching hearts for the constantly increasing number 
of patients. Ergo, it is imperative to dedicate efforts in developing 
effective methods for regenerating damaged myocardium (Parsa, 
Ronaldson and Vunjak-Novakovic 2016).  
Chapter 1 - Introduction 
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Among the novel approaches, cardiac repair has been exploited by 
means of stem cell therapy, and cardiac tissue engineering (TE) 
strategies (Alrefai, et al. 2015). Numerous clinical trials addressing the 
transplantation of various adult stem cell populations for cardiac 
regeneration have been performed in the last few years (Doppler, et al. 
2013). It has been demonstrated that mobilization of endogenous stem 
cells or exogenous administration of a number of stem cell populations 
to injured tissues has resulted in structural regeneration of tissue as well 
as functional improvement (Baraniak and McDevitt 2010). Adult stem 
cell populations are selected on the base of their potential to proliferate, 
migrate and the ability to trans-differentiate into various mature cell 
types. Besides the direct trans-differentiation into cardiomyocytes, stem 
cells can also orchestrate different regenerative mechanisms such as the 
stimulation of resident endogenous myocardial stem cells and paracrine 
actions (Doppler, et al. 2013). However, significant drawbacks could 
weaken the potential of current stem cell therapeutic cardiac strategies. 
Some of the major limitations are related to the: (i) “true” regenerative 
potential of the various cell sources as well as clinical safety (Doppler, 
et al. 2013), (ii) low survival rate of the injected cells (Zhang, et al. 
2001)and, (iii) low engraftment or wash out from the injection site 
(Reffelmann and Kloner 2003). Some authors suggested that functional 
engraftment and survival of transplanted cells might be overcome by 
tissue-engineering techniques (Doppler, et al. 2013). 
In the past decades, cardiac TE has attracted significant interest 
because of the great promise of generating functional tissue constructs 
to be used as 3D models for in vitro studies of cardiac development and 
1.2 Significant highlights of the cardiac muscle 
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disease and eventually for repairing the structure and function of injured 
myocardium (Wang, et al. 2013, Vunjak-Novakovic, Tandon, et al. 
2010). Current cardiac TE methods take advantage from the endogenous 
capacity of (immature) cardiac cells to beat spontaneously and to form 
3D functional syncytia (Moscona 1959, Kelm, et al. 2004) and use 
engineering techniques to make 3D constructs of different size and 
geometry. However, to capitalize the full biological potential of the cells, 
the in vitro systems need to recapitulate several aspects of the native 
tissue milieu (Vunjak-Novakovic, et al. 2014).  
1.2 Significant highlights of the cardiac muscle 
The contractile myocardium is a highly differentiated tissue, with a 
thickness of around ~1 cm in humans and an asymmetrical and helical 
architecture (Akhyari, et al. 2008 , Vu and Kofidis 2012). Mainly, cardiac 
tissue is composed by tightly packed, elongated and rod shaped 
cardiomyocytes (CMs), together with fibroblasts (FBs), endothelial cells 
(ECs) and smooth muscle cells (SMCs). Contractile apparatus of CMs 
consists of sarcomeres arranged in parallel myofibrils highly 
metabolically active. A dense vasculature and extracellular matrix 
(ECM), rich of collagen and laminin, wraps and supports the cell 
network. When specialized pacemaker cells triggers the excitation, 
electrical signals propagate through a 3D syncytium formed by CMs. 
Mechanical stability during contraction and propagation of the signal is 
guaranteed by specialized junctions between cells, adherent and gap 
junctions. Excitation of CMs causes an increase in the amount of 
Chapter 1 - Introduction 
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cytoplasmic calcium, which triggers mechanical contraction and, as a 
result, pumps the blood forward (Odendra, et al. 2011). 
As a whole, the heart can be considered as a dynamic 
electromechanical system where the myocardial tissue experiences 
mechanical stretch during diastole and produces active contraction 
during systole, in a metabolic demanding manner. The wide range of 
physical activities and pathological conditions which the myocardium is 
called to respond, requires high resilience, durability, mechanical 
efficiency and adaptiveness of its structures (Bouten, et al. 2011). In 
detail, within the left ventricle, along a normal cardiac cycle, pressure 
range between 10 and 120 mmHg while the volume change between 40 
and 130 ml (Bouten, et al. 2011). Local mechanical loads can reach 50 
kPa (Bouten, et al. 2011) with 22.9% and 59.2% longitudinal and radial 
systolic mean strains, respectively (Kuznetsova, et al. 2008 ). Young’s 
modulus at end-diastole is reported to range between 200 and 500 KPa 
(Jawad, et al. 2007 ), while active contraction forces of myocardial strips 
isolated from native human ventricles are reported to range between 14.5 
± 4.4 and 22.8 ± 1.4 mN/mm2 for healthy donors (Holubarsch, et al. 
1998). 
As regards to the electrical properties, signals of 1-2 ms in duration 
(Tandon, et al. 2009) excite the cardiac cells, at a resting rate of 1-1.7 
Hz and propagate within the tissue (extracellular fluid conductivity, 3-
12 mS/cm (Durand 2000)), inducing in the tissue an endogenous 
electrical field reported to be in the 0.1-10 V/cm interval (Tandon, et 
al. 2009).  
1.3 Mimicking in vitro the native tissue formation 
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1.3 Mimicking in vitro the native tissue formation 
In vivo, the processes of cell differentiation during embryogenesis and 
adult tissue remodeling are orchestrated by cascades of regulatory factors 
interacting at multiple levels, in space and time. (Grayson, et al. 2009). 
Indeed, as first step, undifferentiated (stem) cells first differentiate into 
specific cell lineages (bone, muscle, nerves and blood vessels) and then 
undergo functional assembly into tissue structures (Grayson, et al. 2009). 
Mainly, four groups of factors have been identified to be instrumental 
for both phases: (i) a structural template for cell attachment and tissue 
formation, (ii) a physiological milieu, (iii) suitable levels of nutrients, 
oxygen and metabolites, and (iv) physical regulatory signals (Grayson, 
et al. 2009, Radisic, Park and Gerecht, et al. 2007).  
According to this biomimetic approach, and given the structural and 
functional complexity of cardiac tissues, two fundamental requisites need 
to be satisfied for the production of organized and functional cardiac 
engineered constructs in vitro. Firstly a scaffold, i.e. an anchoring 
structure presenting native-like tissue mechanical properties and acting 
as a structural and logistic template for the cells should be used. 
Consequently, to address the maturation of the cultured construct in a 
mature-like phenotype, the most relevant physiologic conditions should 
be reestablished in terms of biophysical regulatory signals such as 
perfusion (Radisic, Marsano, et al. 2008), electrical (Tandon, et al. 2009) 
and mechanical stimulation (Fink, et al. 2000, Zimmermann, 
Schneiderbanger, et al. 2002, Birla, Huang and Dennis 2007). 
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A suitable dynamic environment is essential in replicating these 
physiological conditions, and can be recreated and maintained within 
bioreactors, specialized devices that attempt to mimic the physiological 
milieu monitoring and controlling the culture environment eventually 
stimulating the construct (Massai, et al. 2013). Indeed, a bioreactor is 
designed to perform one or more of the following tasks: (i) maintain 
efficient mass transfer between the cultured cells/constructs and the 
culture medium (e.g. temperature, pH, osmolality, levels of oxygen, 
nutrients, metabolites and regulatory molecules), (ii) establish spatially 
uniform, physiologically high cell concentration within the scaffold , and 
(iii) apply physical signals relevant for cardiac development and function 
(e.g. hydrodynamic shear, mechanical, electrical, or combined 
electromechanical stimuli) (Radisic, Park and Gerecht, et al. 2007).  
It has been already shown, that the monitoring and controlling of the 
physicochemical environment in combination with the delivering of 
native-like physical stimuli eventually adapted to the tissue maturation, 
carried out with bioreactor-based platform, allow to obtain engineered 
constructs with improved morphological and functional properties 
(Carrier, et al. 1999, Korossis, et al. 2005, Bilodeau and Mantovani 
2006). Furthermore, several studies have shown that the use of 
bioreactors as closed, standardized, and automated systems guarantees 
more reproducibility and lower contamination risk than the manual 
production processes as well as being sustainable both clinically and 
economically (Archer and Williams 2005, Pörtner, et al. 2005 , Martin, 
Smith and Wendt 2009, Olmer, et al. 2012).  
1.4 Biomimetic approach to cardiac tissue engineering: scaffolds, biophysical 
stimulation and bioreactors 
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1.4 Biomimetic approach to cardiac tissue 
engineering: scaffolds, biophysical stimulation and 
bioreactors 
For an effective in vitro biomimetic tissue generation strategy, a 
synergistic combination of cells, scaffolds and culture conditions within 
tailored bioreactors is needed (Vunjak-Novakovic, Tandon, et al. 2010). 
The aim is to obtain cardiac engineered constructs, which are close to 
the native tissue in morphology and function, thus offering new 
perspectives to basic cardiac research and tissue replacement therapy. 
Among the different biophysical conditioning, herein we focus on the 
mechanical stimulation. Indeed, the heart starts functioning early in 
development and, thus, much of the growth and reorganization that 
occurs in utero is in the presence of changing mechanical stimuli. 
Furthermore, alterations in the cardiac function due to disease usually 
are correlated to alterations in the mechanical function of the organ, 
which alters the mechanical load on CMs. For these reasons, several 
studies have been addressed to assess the effects of various mechanical 
stimuli on CMs in vitro (Stoppel, Kaplan and Black 2016). Different 
typologies of scaffold and biophysical stimulations have been exploited 
so far (Massai, et al. 2013, Vunjak-Novakovic, Tandon, et al. 2010, Hirt, 
Hansen and Eshenhagen 2014), but a comprehensive review is beyond 
the scope if this introduction. However, a brief introduction on the 
scaffold being currently used is presented and an excursus of some main 
findings concerning the delivering of mechanical stimuli by means of 
bioreactors is reported.  
Chapter 1 - Introduction 
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1.4.1 Scaffolds  
An ideal scaffold should mimic the native heart matrix properties, 
and actively interact with the cells at different scales: from “molecular”, 
(incorporating ligands and growth factors) through “cellular” (migration, 
cell–cell contacts, and stiffness), to the tissue scale (Young Modulus) 
(Langer and Tirrell 2004, Lutolf and Hubbell 2005, Tibbitt and Anseth 
2009 ). Furthermore, a tunable degradation of the material is essential 
to adapt the structural support of the scaffold with the developing tissue 
(Jockenhoevel and Flanagan, 2011). Among the several ways that have 
been followed, four main approaches stand out: (1) the use of 
prefabricated matrices, such as collagen and gelatine sponges (Li, et al. 
1999, Radisic, Park and Shing, et al. 2004, Zhang, et al. 2015), (2) 
decellularized heart tissue (Ott, et al. 2008, Wang, et al. 2013), (3) cell 
sheets (Shimizu, et al. 2002, Matsuura, et al. 2013) and, (4) hydrogel 
techniques (Eschenhagen, et al. 1997 , Hansen, et al. 2010, Williams, et 
al. 2015) Regardless of the approach, the biomechanical properties of the 
employed scaffold should mimic the hierarchical structure and 
mechanical properties of the native heart matrix. That serves as 
informational template for regulating the cell-cell and cell-substrate 
interaction eventually addressing the cell behavior. Moreover, during 
culture, cells need to remodel the initial matrix gradually replacing it 
with its own matrix. Biomaterials used for scaffold production could 
include biological molecules (e.g., alginate, collagen, fibrin, and 
hyaluronan) and/or synthetic polymers (e.g., polylactic and polyglycolic 
acids and their copolymers, polycaprolactone), where a specific 
biomimetic architecture is approached to promote the differentiation and 
1.4 Biomimetic approach to cardiac tissue engineering: scaffolds, biophysical 
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functional organization of the seeded cells (Govoni, C., et al. 2013). 
Recently, fibrin (gel) is becoming largely used as scaffold candidate by 
virtue of its “physiological role” in tissue formation. Indeed a successful 
tissue engineering strategy should mimic the tissue regeneration process 
which is nearly related to haemostasis (Jockenhoevel and Flanagan, 
2011). Numerous advantages have been highlighted for the use of fibrin. 
Starting with a compound of cells suspended within the fibrinogen 
solution, the fibrin gel scaffolds grant high seeding efficiency and 
homogenous cell distribution by gelation entrapment, eventually 
minimizing loss of cells. (Jockenhoevel, Zund, et al. 2001 ). 
Polymerization and degradation of the fibrin gel is manageable and can 
be tuned to the tissue development by using the protease inhibitors, such 
as aprotinin and tranexamic acid (Cholewinski, et al. 2009). The fibrin 
gel allows also to covalently embed grow factors and modulate their 
release (Wirz, et al. 2011). Noteworthy the compact cell-seeded structure 
that results from gelation provides an adequate hardiness for mechanical 
loading (Mol, et al. 2005).  
Improved cardiac tissue structure and higher force development have 
been observed in fibrin based engineered constructs that were exposed 
to cyclic stretch by motorized stretching devices (Birla, Huang and 
Dennis 2007, Morgan and Black III 2014, Salazar, et al. 2015) or those 
cultured in auxotonic conditions (Hansen, et al. 2010). 
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1.4.2 Mechanical stimulation and bioreactors  
Individually delivered or coupled mechanical and electrical 
conditioning have been identified as key treatments for biomimetic 
culture (Stoppel, Kaplan and Black 2016). Investigations carried out in 
the last decade shown their crucial role during cardiac development, in 
supporting cell differentiation and self-assembling and for further 
cardiomyocyte maturation, promoting the overall structure organization 
and, thus, the functionality of the engineered constructs. (Eschenhagen, 
et al. 1997 , Zimmermann, Schneiderbanger, et al. 2002, Isenberg and 
Tranquillo 2003, Radisic, Park and Shing, et al. 2004, Feng, et al. 2005 
, Zimmermann, et al. 2006, Wang, et al. 2013, Morgan and Black III 
2014, Godier-Furnémont, et al. 2015.) Dealing with the mechanical 
stimulation, different load conditions on engineered cardiac constructs 
have been investigated so far. To simulate isometric contraction, the 
static load condition has been for first approached showing to have 
influence in the tissue organization and contractile activity under pacing 
(Eschenhagen, et al. 1997 ). Subsequently, the phasic stretching (quasi-
isotonic contraction), as alternative load mode, has been exploited by 
means of commercial or custom-made motorized devices within a range 
of strain of 10-20% and a range of frequencies of 1-2Hz. If compared with 
static controls, constructs that were exposed to phasic stretch by 
motorized stretching devices showed: (i) improved tissue maturation and 
enhanced expression of junctional proteins as well as matrix fiber 
reorganization (Fink, et al. 2000 , Zimmermann, Schneiderbanger, et al. 
2002, Feng, et al. 2005 , Kensah, et al. 2011, Salazar, et al. 2015, Morgan 
and Black III 2014) and, (ii) increase in the active, systolic force (also 
1.4 Biomimetic approach to cardiac tissue engineering: scaffolds, biophysical 
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referred to as twitch tension [TT]) and recapitulation of the Frank-
Starling mechanism (Zimmermann, Schneiderbanger, et al. 2002, 
Tulloch, et al. 2011). A third way to load the engineered tissues was 
suspending them between resilient mounts to facilitate the so-called 
auxotonic contraction. This flexible loading approach seems to resemble 
the physiologic contraction cycle quite closely and showed to improve 
the tissue maturation as well as the systolic force (Zimmermann, et al. 
2006, Hansen, et al. 2010, Schaaf, et al. 2014). However, its application 
is weaken by the fact that, as far as the constructs develop their 
contractile properties, a variable load against which to exert contraction 
should be tuned consequently (W. Zimmermann, 2013).  
From the very first simple stretching devices, used to delivered 
uniaxial stimulation (Fink, et al. 2000 , Zimmermann, Schneiderbanger, 
et al. 2002), the engineering design of the bioreactors has been improved, 
initially, ameliorating the instrumentation to control the stimulation 
protocols and making them compatible with several tissue constructs 
(Birla, Huang and Dennis 2007). Furthermore, some stretching devices 
started to integrate the electrical stimulation to deliver combined 
stimulation patterns (Stoppel, Kaplan and Black 2016, Wang, et al. 
2013). Nevertheless, to assess the effects of mechanical stretch, neo 
constructs needed still to be transferred within a measurement device 
(e.g. a standard test instrument or an organ bath chamber), making 
force measurement (active and passive) predominantly used as end-point 
analysis (Kensah, et al. 2011). In 2011, Kensah and coworkers developed 
a bioreactor-based platform, incorporating mechanical stimulation and 
direct real-time contraction force measurement (Kensah, et al. 2011). 
Chapter 1 - Introduction 
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The device was also designed for including additional functions, such as 
electric pacing and culture medium perfusion and the possibility of 
(fluorescence) microscopic assessment during continuous cultivation 
(Kensah, et al. 2011). Following this configuration, a number of distinct 
bioreactors have been devised to incorporate one or more of the 
mentioned stimulations or the assessment of physical characteristics 
(Govoni, Lotti, et al. 2014, Salazar, et al. 2015). Yet, even if widely 
recognized that the engineering design of the bioreactors should permit 
to recapitulate as close as possible the physiological stimuli experienced 
in vivo, the ideal culture platform is still at the horizon (Liaw and 
Zimmermann 2016, Salazar, et al. 2015). Indeed, bioreactors for 
culturing engineered cardiac tissues have been limited by several factors: 
 the mechanical stimulation pattern is limited in terms of 
waveforms, frequency and duty cycle duration, bounding the 
possibility to mimic the wide range of conditions experienced 
by the heart tissue in vivo (Birla, Huang and Dennis 2007) 
 measurement of mechanical properties of tissue engineered 
constructs typically require interruption of the cultivation 
process and therefore provide only end-point measurements 
of the respective samples (Fink, et al. 2000 ) 
 physical and functional properties (e.g. mechanical stiffness, 
active force) of engineered constructs (Kensah, et al. 2011) 
are never monitored in combination with physicochemical 
parameters 
1.5 Research outline 
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 systems are not able to adapt the stimulation to the actual 
maturation stage of the construct; strain/load cannot be 
adjusted on the basis of the measured force exerted by the 
construct (W. Zimmermann, 2013) 
1.5 Research outline 
In order to overcome some limitation of the bioreactors currently used 
in the generation and characterization of thick-relevant engineered 
cardiac tissues, the design and the development of a novel advanced 
bioreactor is proposed in this work.  
In its most advanced operational mode, the bioreactor is capable to: 
(i) apply native-like or pathologic stimuli (cyclic strain) (ii) monitor in 
real-time both the milieu parameters (e.g. oxygen tension, pH) and the 
developing mechanical stiffness of mm-scale engineered cardiac tissues. 
Towards the final validation of the bioreactor performances, the effects 
of the cyclic strain imparted by the device on cardiac tissue models has 
been assessed by the development of on-purpose fibrin-based engineered 
cardiac tissues, characterized by a novel mixture composition devised for 
this application. In detail, chapters are organized as follow. 
Chapter II –  Design and implementation of a cyclic strain-based 
bioreactor to train engineered cardiac tissues. 
In this chapter, the engineering design and the development of a novel 
advanced bioreactor is illustrated. The system has been developed to 
deliver native-like or pathologic stimuli (cyclic strain) to engineered 
cardiac constructs in a wide range of strains and frequencies by means 
Chapter 1 - Introduction 
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of a reliable linear actuator. The bioreactor is also equipped with a 
system of sensors to monitor in real-time the evolution of (1) the culture 
parameters, related to the metabolic behavior of the tissues, and (2) the 
physical response of the mechanically stimulated constructs along the 
culture in a non-destructive manner. Finally, a monitoring and control 
unit oversees the mechanical stimulation and the acquisition of the 
signals from the sensors, allowing the communications from and toward 
the user thanks to a dedicated purpose-built software. The architectural 
design and the constitutive mechanical, electronic and software 
subsystems are presented in detail. A preliminary validation in house is 
reported. 
 
Chapter III - Effects of cyclic strain on maturation, contractility and 
mechanical properties of Engineered Cardiac Tissues. A proof of concept. 
In this chapter, fibrin-based, ring shaped Engineered Cardiac Tissues 
were generated and cultured within the bioreactor. The effects of cyclic 
strain on the maturation, alignment, modification of the extracellular 
matrix and on the elastic and functional properties of ECTs was 
evaluated by means of histologic assessments, mechanical testing and 
response to external electrical pacing along the culture.  
Chapter IV - Conclusions and Future Perspectives. 
In this chapter, concluding observations of each section are 
summarized. Suggestions on future perspectives based on the obtained 
results and ongoing assessments are provided. 
References 
Akhyari, P., Kamiya, H., A. Haverich, M. Karck, and A. Lichtenberg. 
"Myocardial tissue engineering: the extracellular matrix." Eur J 
Cardiothorac Surg 34, no. 2 (2008 ): 229-41. 
Alrefai, M.T., D. Murali, Paul A., K.M. Ridwan, J.M. Connell, and 
Shum-Tim D. "Cardiac tissue engineering and regeneration using cell-
based therapy." Stem Cells Cloning, 2015: 81–101. 
Archer, R., and D.J. Williams. "Why tissue engineering needs process 
engineering." Nature Biotechnology 11, no. 23 (2005): 1353-1355. 
Baraniak, P.R., and T.C. McDevitt. "Stem cell paracrine actions and 
tissue regeneration." Regen Med 5, no. 1 (2010): 121–143. 
Bilodeau, K., and D. Mantovani. "Bioreactors for tissue engineering: 
focus on mechanical constraints. A comparative review." Tissue 
Engineering 12, no. 8 (2006): 2367-2383. 
Birla, R.K., Y.C. Huang, and R.G. Dennis. "Development of a novel 
bioreactor for the mechanical loading of tissue-engineered heart muscle." 
Tissue Engineering 13, no. 9 (2007): 2239-48. 
Bouten, C.V., P.Y. Dankers, A. Driessen-Mol, S. Pedron, and A.M.: 
Baaijens, F.P. Brizard. "Substrates for cardiovascular tissue 
engineering." Adv Drug Deliv Rev 63, no. 4-5 (2011): 221-41. 
Carrier, R.L., et al. "Cardiac tissue engineering: cell seeding, cultivation 
parameters, and tissue construct characterization." Biotechnol Bioeng 
64, no. 5 (1999 ): 580-9. 
Cholewinski, E., M. Dietrich, T. C. Flanagan, T. Schmitz-Rode, and S. 
Jockenhoevel. "Tranexamic acid- an alternative to aprotinin in fibrin-
based cardiovascular tissue engineering." Tissue Engineering Part A, 
2009. 
 16 
 
Cleutjens, J.P., W.M. Daemen M.J. Blankesteijn, and Smits J.F. "The 
infarcted myocardium: simply dead tissue, or a lively target for 
therapeutic interventions." Cardiovasc Res 44, no. 2 (1999): 232-41. 
De Celle, T., J.P. Cleutjens, W.M. Blankesteijn, J.J. Debets, J.F. Smits, 
and B.J. Janssen. "Long-term structural and functional consequences of 
cardiac ischaemia-reperfusion injury in vivo in mice." Exp Physiol 89, 
no. 5 (2004): 605-15. 
Doppler, S.A., M-A. Deutsch, R. Lange, and M. Krane. "Cardiac 
regeneration: current therapies—future concepts." J Thorac Dis, no. 5 
(2013): 683–697. 
Durand, D. M. "Electric Stimulation of Excitable Tissue." Chap. 17 in 
The Biomedical Engineering Handbook. Joseph D. Bronzino, 2000. 
Eschenhagen, T., et al. "Three-dimensional reconstitution of embryonic 
cardiomyocytes in a collagen matrix: a new heart muscle model system." 
FASEB J 11, no. 8 (1997 ): 683-94. 
Feng, Z., T. Matsumoto, Y. Nomura, and T. Nakamura. "An electro-
tensile bioreactor for 3-D culturing of cardiomyocytes - a bioreactor 
system that simulates the myocardium's electrical and mechanical 
response in vivo." IEEE Eng Med Biol 24, no. 4 (2005 ): 73-9. 
Fink, C., S. Ergün, D. Kralisch, U. Remmers, J. Weil, and T. 
Eschenhagen. "Chronic stretch of engineered heart tissue induces 
hypertrophy and functional improvement." FASEB J 14, no. 5 (2000 ): 
669-79. 
Godier-Furnémont, A.F., et al. "Physiologic force-frequency response in 
engineered heart muscle by electromechanical stimulation." Biomaterials 
60 (2015.): 82-91. 
Govoni, M., et al. "An innovative stand-alone bioreactor for the highly 
reproducible transfer of cyclic mechanical stretch to stem cells cultured 
in a 3D scaffold." J Tissue Eng Regen Med 8, no. 10 (2014): 787-93. 
 17 
 
Govoni, M., Muscari C., C. Guarnieri, and E. Giordano. 
"Mechanostimulation Protocols for Cardiac Tissue Engineering." 2013. 
Grayson, W.L., T.P. Martens, G.M. Eng, M. Radisic, and G. Vunjak-
Novakovic. "Biomimetic Approach to Tissue Engineering." Semin Cell 
Dev Biol 20, no. 6 (2009): 665–673. 
Hansen, A., et al. "Development of a drug screening platform based on 
engineered heart tissue." Circ Res 107, no. 1 (2010): 35-44. 
Hirt, M.N., A. Hansen, and T. Eshenhagen. "Cardiac Tissue 
Engineering: State of the Art." Circulation Research 114, no. 2 (2014): 
354-67. 
Holubarsch, C., et al. "Shortening versus isometric contractions in 
isolated human failing and non-failing left ventricular myocardium: 
dependency of external work and force on muscle length, heart rate and 
inotropic stimulation." Cardiovasc Res 37, no. 1 (1998): 46-57. 
Isenberg, B.C., and R.T. Tranquillo. "Long-term cyclic distention 
enhances the mechanical properties of collagen-based media-
equivalents." Ann Biomed Eng 31, no. 8 (2003): 937-49. 
Jawad, H., N.N. Ali, A.R. Lyon, Q.Z. Chen, S.E. Harding, e A.R. 
Boccaccini. «Myocardial tissue engineering: a review.» J Tissue Eng 
Regen Med 1, n. 5 (2007 ): 327-42. 
Jockenhoevel, S., and T.C. Flanagan. "Cardiovascular Tissue 
Engineering Based on Fibrin-Gel-Scaffolds." In Tissue Engineering for 
Tissue and Organ Regeneration. Daniel Eberli, 2011. 
Jockenhoevel, S., et al. "Fibrin gel-advantages of a new scaffold in 
cardiovascular tissue engineering." Eur J Cardiothorac Surg 19, no. 4 
(2001 ): 424-30. 
Kelm, J.M., E. Ehler, L.K. Nielsen, S. Schlatter, J.C. Perriard, and M. 
Fussenegger. "Design of artificial myocardial microtissues." Tissue Eng 
10, no. 1-2 (2004): 201-14. 
 18 
 
Kensah, G., et al. "A novel miniaturized multimodal bioreactor for 
continuous in situ assessment of bioartificial cardiac tissue during 
stimulation and maturation." Tissue Eng Part C 17, no. 4 (2011): 463-
73. 
Korossis, SA., F. Bolland, JN. Kearney, J. Fisher, and E. Ingham. 
Bioreactors in Tissue Engineering. Vol. 2, in Topics in Tissue 
Engineering. N. Ashammakhi & R.L. Reis, 2005. 
Kuznetsova, T., et al. "Left ventricular strain and strain rate in a general 
population." Eur Heart J 29, no. 16 (2008 ): 2014-23. 
Langer, R., and D.A. Tirrell. "Designing materials for biology and 
medicine." Nature 428 (2004): 487-492. 
Li, R.K., Z.Q. Jia, R.D. Weisel, D.A. Mickle, A. Choi, and T.M. Yau. 
"Survival and Function of Bioengineered Cardiac Grafts." Circulation 
100, no. II (1999): II63-II69. 
Liaw, N.Y., and W.H. Zimmermann. "Mechanical stimulation in the 
engineering of heart muscle." Adv Drug Deliv Rev., 2016. 
Lu, L., et al. "Design and validation of a bioreactor for simulating the 
cardiac niche: a system incorporating cyclic stretch, electrical 
stimulation, and constant perfusion." Tissue Eng Part A 19, no. 3-4 
(2013): 403-14. 
Lutolf, M.P., and J.A. Hubbell. "Synthetic biomaterials as instructive 
extracellular microenvironments for morphogenesis in tissue 
engineering." Nat Biotechnol 23, no. 1 (2005): 47-55. 
Martin, I., T. Smith, and D. Wendt. "Bioreactor-based roadmap for the 
translation of tissue engineering strategies into clinical products." Trends 
Biotechnol 27, no. 9 (2009): 495-502. 
Massai, D., et al. "Bioreactors as engineering support to treat cardiac 
muscle and vascular disease." Journal of Healthcare Engineering 3, no. 
4 (2013): 329-70. 
 19 
 
Matsuura, K., Y. Haraguchi, T. Shimizu, and T. Okano. "Cell sheet 
transplantation for heart tissue repair." J Control Release 169, no. 3 
(2013). 
Mol, A., et al. "Fibrin as a cell carrier in cardiovascular tissue 
engineering applications." Biomaterials 26, no. 16 (2005): 3113-21. 
Morgan, K.Y., and L.D. Black III. Creation of Bioreactor for the 
Apllication of Variable Amplitude Mechanical Stimulation of Fibrin Gel-
Based Engineered Cardiac Tissue. Vol. 1181, in Cardiac Tissue 
Engineering: Methods and Protocols, Methods in Molecular Biology. 
Milica Radisic and Lauren D. Black III, 2014. 
Moscona, A.A. "Tissues from dissociated cells." Sci Am 200 (1959): 132-
134. 
Odendra, D., L. Chiu, L. Reis, F. Rask, K. Chiang, and M. Radisic. 
"Biomaterials for Tissue Engineering Applications. A review of the Past 
and Future Trends." Chap. 15 in Cardiac Tissue Engineering. Burdick, 
JA; Mauck, RL, 2011. 
Olmer, R., et al. "Suspension culture of human pluripotent stem cells in 
controlled, stirred bioreactors." Tissue Eng Part C Methods 18, no. 10 
(2012): 772-84. 
Ott, H.C., et al. «Perfusion-decellularized matrix: using nature's 
platform to engineer a bioartificial heart.» Nature Medicine 14 (2008): 
213 - 221. 
Parsa, H, K. Ronaldson, and G. Vunjak-Novakovic. "Bioengineering 
methods for myocardial regeneration." Adv Drug Deliv Rev 96 (2016): 
195-202. 
Pörtner, R., S. Nagel-Heyer, C. Goepfert, P. Adamietz, and N.M. 
Meenen. "Bioreactor design for tissue engineering." J Biosci Bioeng 100, 
no. 3 (2005 ): 235-45. 
Radisic, M., A. Marsano, R. Maidhof, Y. Wang, and G. Vunjak-
Novakovic. "Cardiac tissue engineering using perfusion bioreactor 
systems." Nat Protoc 3, no. 4 (2008): 719-38. 
 20 
 
Radisic, M., et al. "Functional assembly of engineered myocardium by 
electrical stimulation of cardiac myocytes cultured on scaffolds." PNAS 
101, no. 52 (2004): 18129–18134. 
Radisic, M., H. Park, S. Gerecht, C. Cannizzaro, R. Langer, and G. 
Vunjak-Novakovic. "Biomimetic approach to cardiac tissue 
engineering." Philos Trans R Soc Lond B Biol Sci 362, no. 1484 (2007): 
1357–1368. 
Reffelmann, T., and R.A. Kloner. "Cellular cardiomyoplasty-
cardiomyocytes, skeletal myoblasts, or stem cells for regenerating 
myocardium and treatment of heart failure?" Cardiovasc Res 58, no. 2 
(2003): 358-68. 
Roger, V.L., et al. "Heart disease and stroke statistics--2012 update: a 
report from the American Heart Association." Circulation 125, no. 1 
(2012). 
Salazar, B.H., A.T. Cashion, R.G. Dennis, and R.K. Birla. 
"Development of a Cyclic Strain Bioreactor for Mechanical 
Enhancement and Assessment of Bioengineered Myocardial Constructs." 
Cardiovasc Eng Technol. 6, no. 4 (2015): 533-45. 
Schaaf, S., A. Eder, I. Vollert, A. Stohr, A. Hansen, and T. Eschenhagen. 
Generation of Strip-Format Fibrin-BAsed Engineered Heart Tissue 
(EHT). Vol. 1181, in Cardiac Tissue Engineering: Methods and 
Protocols, Methods in Molecular Biology. Milica Radisic and Lauren D. 
Black III, 2014. 
Shimizu, T., et al. "Fabrication of pulsatile cardiac tissue grafts using a 
novel 3-dimensional cell sheet manipulation technique and temperature-
responsive cell culture surfaces." Circ Res 90, no. 3 (2002): e40. 
Stoppel, W.L., D.L. Kaplan, and L.D.III Black. "Electrical and 
mechanical stimulation of cardiac cells and tissue constructs." Adv Drug 
Deliv Rev, 2016: 135-55. 
Tandon, N., et al. "Electrical stimulation systems for cardiac tissue 
engineering." Nat Protoc 4, no. 2 (2009): 155-73. 
 21 
 
Tibbitt, M.W., and K.S. Anseth. "Hydrogels as extracellular matrix 
mimics for 3D cell culture." Biotechnol Bioeng 103, no. 4 (2009 ): 655-
63. 
Tulloch, N.L., et al. "Growth of engineered human myocardium with 
mechanical loading and vascular coculture." Circ Res 109, no. 1 (2011): 
47-59. 
Vu, D.T., and T. Kofidis. "Myocardial Restoration: Is It the Cell or the 
Architecture or Both?" Cardiology Research and Practice, 2012. 
Vunjak-Novakovic, G., et al. "Challenges in cardiac tissue engineering." 
Tissue Eng Part B 16, no. 2 (2010): 169-87. 
Vunjak-Novakovic, G., T. Eschenhagen, and C. Mummery. "Myocardial 
Tissue Engineering: In Vitro Models." Cold Spring Harb Perspect Med, 
2014. 
Wang, B., et al. "Myocardial scaffold-based cardiac tissue engineering: 
application of coordinated mechanical and electrical stimulations." 
Langmuir 29, no. 35 (2013): 11109-17. 
Williams, C., et al. "Cardiac extracellular matrix-fibrin hybrid scaffolds 
with tunable properties for cardiovascular tissue engineering." Acta 
Biomater, 2015: 84-95 . 
Wirz, S., et al. "Influence of platelet-derived growth factor-AB on tissue 
development in autologous platelet-rich plasma gels." Tissue Eng Part 
A. 17, no. 13-14 (2011): 1891-9. 
Zhang, B., M. Montgomery, L. Davenport-Huyer, A. Korolj, and M. 
Radisic. "Platform technology for scalable assembly of instantaneously 
functional mosaic tissues." Sci Adv 1, no. 7 (2015). 
Zhang, M., D. Methot, V. Poppa, Y. Fujio, K. Walsh, and C.E. Murry. 
"Cardiomyocyte grafting for cardiac repair: graft cell death and anti-
death strategies." J Mol Cell Cardiol 33, no. 5 (2001): 907-21. 
 22 
 
Zimmermann, W., et al. «Engineered heart tissue grafts improve systolic 
and diastolic function in infarcted rat hearts.» Nat Med 12 (2006): 452–
458. 
Zimmermann, W.H. "Biomechanical regulation of in vitro cardiogenesis 
for tissue-engineered heart repair." Stem Cell Research & Therapy 4, no. 
137 (2013). 
Zimmermann, W.H., et al. «Tissue engineering of a differentiated cardiac 
muscle construct.» Circ Res 90 (2002): 223–230 . 
 
Chapter 2  
Design and implementation of a cyclic strain-
based bioreactor to train engineered cardiac 
tissues  
2.1 Introduction 
Due to the structural and functional complexity of cardiac tissue, 
successful strategies of cardiac tissue engineering (TE) for the in vitro 
generation of functional engineered cardiac tissues to be used as 
substitutes or models for drug screening require in-depth investigations 
on cardiac tissue developmental aspects and adequate biochemical and 
biophysical stimulations during culture (Bilodeau and Mantovani 2006, 
Vunjak-Novakovic, et al. 2010).  
As mentioned in the first chapter, a suitable dynamic culture 
environment is essential in replicating the physiological conditions in 
vitro. This can be achieved by the use of bioreactors, specialized devices 
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that attempt to mimic the physiological milieu by monitoring and 
controlling the culture environment and eventually stimulating the 
construct (Massai et al., 2013). Indeed, a bioreactor is designed to 
perform one or more of the following tasks: (i) maintain efficient mass 
transfer between the cultured cells/constructs and the culture medium 
(e.g. temperature, pH, osmolality, levels of oxygen, nutrients, 
metabolites and regulatory molecules), (ii) guarantee spatially uniform, 
physiologically high cell concentration within the constructs, and (iii) 
apply physical signals relevant for the development and function of the 
engineered tissue (e.g. hydrodynamic shear, mechanical, electrical, or 
combined electromechanical stimuli) (Radisic, et al. 2007).  
The monitoring and controlling of the physicochemical environment, 
in combination with the delivering of native-like physical stimuli carried 
out with bioreactor-based platform, allows to obtain engineered 
constructs with improved morphological and functional properties 
(Carrier, et al. 1999, Korossis, et al. 2005, Bilodeau and Mantovani 
2006). In particular, mechanical stimulation has been shown to be crucial 
during cardiac development, supporting cell differentiation and self-
assembling, and for further cardiomyocyte maturation, guiding the 
overall structure organization and, thus, the functionality of the 
engineered cardiac constructs (Kensah, et al. 2011, Hirt, Hansen and 
Eshenhagen 2014). It has been also highlighted the importance in 
monitoring the evolution of tissue maturation in order to adequately 
train the neo-tissue (Zimmermann, 2013). In order to overcome some 
limitations of the bioreactors currently used in the generation and 
mechanical conditioning of mm-scale cardiac tissue, a novel advanced 
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bioreactor-based platform is herein proposed. In this chapter, the 
engineering design and the development of the bioreactor components 
are presented. The device is proposed as a system meant to deliver 
native-like or pathologic stimuli (cyclic strain) to engineered cardiac 
constructs in a wide range of strains and frequencies by means of a 
reliable linear actuator. The bioreactor is also equipped with a system of 
sensors to monitor in real-time the evolution of (1) the culture 
parameters, related to the metabolic behavior of the tissues, and, (2) the 
physical response of the mechanically stimulated constructs during the 
culture in a non-destructive manner. Finally, a monitoring and control 
unit oversees both the mechanical stimulation and the acquisition of the 
signals from the sensors, allowing the communications from and toward 
the user thanks to a dedicated purpose-built software. Furthermore, the 
adopted technical solutions, in terms of hardware and software 
architecture, allow for an expansion of the device functionalities. 
2.2 Bioreactor description 
2.2.1 Device requirements  
As the bioreactor was designed to work into a standard incubator, all 
the materials employed in its design and fabrication were chosen 
accordingly. Furthermore, to assure full compatibility with good 
manufacturing practice (GMP) standards, few general principles, 
generally considered the “basics”, were used as a blueprint for the design 
(Partap, Plunkett and O’Brien 2004, Mantero, et al. 2007). Table 1 
summarizes these key points.  
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Table 1 General requirements 
General Requirements Description 
Simplicity in the design 
It should be quick to assemble and 
disassemble 
Compactness in size 
It should fit in a standard size 
incubator 
Cytocompatibility and corrosion‐
resistance 
The materials in contact with 
culture medium/cells must be inert, 
while the materials used for external 
parts must be usable at 37ºC in 
humid atmosphere 
Facilitate monitoring of cell/tissue 
quality 
The culture chamber in should be in 
translucent material 
Ability to ensure the culture of 
tissue samples under sterile 
conditions 
The sealing of the moving parts is 
crucial and must be carefully taken 
into account 
Ease of sterilization and sterility 
maintenance 
It should be possible to sterilize by 
autoclaving or other methods 
(resistance of the material at T ≥ 
120ºC for at least 1h) 
Ease of use 
It should be easy to fix the 
cells/scaffold in place in sterile 
conditions under a laminar flow 
hood –simple to use also for non-
trained staff 
Possibility of housing a 
experimentally significant number of 
specimens 
A minimum of three samples should 
be cultured for each experiment 
Scalability  
The design should be relatively easy 
to enlarge without changing its 
characteristics 
In detail, the bioreactor design was driven by four main requirements:  
- to apply accurate, controllable and user-defined displacement 
(namely cyclic strain) in the range of (i) 5 - 100% of strain for 
ring shaped/strip-like constructs 2-15 mm in length and, (ii) 1-
6 Hz of frequency. 
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- to acquire, in real-time, culture bulk parameters: (i) dissolved 
oxygen tension (range 0-21%) and, (ii) pH (0-11 pH).1  
- to measure, in real-time, the force exerted by the cardiac 
engineered tissue and assess changings in the construct 
mechanical properties along the culture (forces in the range 0-
10N ). 
- to allow the user in (1) setting the culture condition in terms 
of strain and waveform, (2) calibrate, display in real-time/save 
the signals form the sensors and (3) run tests for the 
mechanical characterization (as in a standard commercial 
Testing System) of the tissues, by means of a software user 
friendly interface. 
2.2.2 Architectural design and constitutive elements 
The architecture of the bioreactor is depicted in Figure 1 and a 
description of the components in Figure 2. To confer the maximum 
modularity, the bioreactor has been designed to be composed by four 
main components: (1) a culture unit, (2) a structural framework, (3) a 
stimulation and sensing unit and (4) a monitoring and control unit.  
The culture unit contains and holds the constructs surrounded by the 
culture medium; the lid of the culture chamber seals and is capable to 
accommodate up to four immersed sensors.  
                                        
1 Acquisition of CO2 and temperature parameters were also considered as 
extension of the current design 
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The structural framework is the external chassis which anchors the 
mutual position of all the components of the bioreactor and allows the 
actuator to deliver the mechanical stimulus to the 3D construct on one 
side of the culture unit, while monitoring the force exerted by means of 
a load cell on the contralateral extremity.  
The stimulation and sensing unit comprises two distinct subunits. 
The stimulation unit is composed by the linear actuator and the position 
transducer. Indeed, in the design of the actuation system the use of the 
motor which have been selected, requires the implementation of a 
feedback loop control strategy and hence the presence of a position 
transducer. The sensing unit is composed by the pH, O2 sensors and the 
force sensor. 
Finally, the monitoring and control unit oversees (i) the feedback loop 
motion control strategy, (ii) the acquisition of the signals from the 
sensors and, (iii) the communications from and toward the user, using a 
real-time structure. It is composed by software and hardware 
components, i.e. a real-time controller, an analog input module and a 
power module, which are boxed in a case and a PC. In Figure 2 a picture 
of the actual device is shown.  
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Figure 1: Architecture of the bioreactor and its four main components: 
culture unit (1), structural framework (2), stimulation and sensing unit (3), 
monitoring and control unit (4). With regard to the stimulation and sensing 
unit: green lines indicate the stimulation components which embed: the linear 
actuator (a) and the position transducer (b) while grey lines indicate the 
sensing components, i.e., pH (c), O2 (d) sensors or currently unused spots for 
two more sensors (e.g. CO2 and temperature(e, f)) and load cell (g). 
 
Figure 2: Figure A shows the culture unit(1) assembled within the 
structural framework (2) and the components of the stimulation and sensing 
unit(3), i.e linear actuator (a), position transducer (b) and the pH, O2 and 
load cell sensors (c,d,g). Figure B shows the (4) monitoring and control unit 
The mechanical design has been carried out by means of SolidWorks® 
(Dassault Systemes, FR). The NI (National Instruments, TX, USA) 
hardware and the LabView® Graphical Programming Environment 
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software (National Instruments, TX, USA) were considered the most 
appropriate choice for the fulfilment of the project requisites.  
2.2.3 Culture unit design 
The components herein described compose the so called culture unit. 
They enter directly in contact with the constructs and the culture 
medium. Consequently, this is the solely unit which the components 
undergo to the sterilization process. 
The culture chamber is a transparent autoclavable rectangular vessel 
(140 x 80 x 75 mm3 with a priming volume of ~100 ml). The internal 
geometry is symmetrical and presents two lateral holes 40 mm in 
diameter along the longitudinal section which merge into a quadrangular 
central well (where the constructs are placed) opened in the upper part 
where the lid seats (Figure 3C). All the internal edges are rounded in 
order to avoid stagnation points or discontinuities, fissures, interstices, 
holes, which are preferable targets for microbial contamination. It has 
been made out of Polycarbonate (PC) which is a strong, tough and 
optically transparent thermoplastic polymer. Besides, many 
polycarbonate grades are used in medical applications and can be 
sterilized using steam at 120ºC, gamma radiation, or by the ethylene 
oxide (EtO) method. 
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Figure 3: Culture chamber views: (A) longitudinal (B) cross,  
and (C) top view 
Two lateral cylindrical walls (left and right wall) fit into the lateral 
holes of the chamber with the double function of (1) allowing the shaft, 
where the constructs are hold by the grasping system, to smoothly shift 
and deliver the motion, (2) sealing the chamber from the external by 
means of silicon bellows (Figure 4). It is functional to label one side of 
the culture unit as the actuation side, where the shaft couples the 
actuator, and the contralateral as the sensing side, where it couples the 
force sensor. 
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Figure 4:  Culture chamber and lateral walls sub-assembly 
The walls are made out of Polyoxymethylene (POMc), also known 
with the commercial name of Delrin®, an engineering thermoplastic 
material used in precision parts requiring high stiffness, low friction and 
excellent dimensional stability. The correct positioning of the walls 
within the chamber is guaranteed by the presence of a bulge on top of 
them while the insertion and extraction are assisted by a handle 
integrated on the external surface. 
Along the longitudinal section the wall external profile fits, on one 
side, within the chamber lateral holes and seals the chamber by means 
of an O-ring, while allows, from the other side, to house the silicone 
bellow which wraps the shaft and seals the chamber. They are centrally 
drilled with a circular profile while a thin square profile is maintained at 
the bottom to prevent the shaft spinning during the mounting operations 
(Figure 5B). To reduce the friction of the moving shaft, the circular 
portion of the wall houses a cylindrical flanged lubricant-free bearing 
(iglidur A350, Igus, UK) (Figure 5B). This specific kind of bearing is 
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well-suited for oscillating applications, is temperature-resistant (up to 
180ºC) and FDA compliant. 
 
Figure 5: (A) Culture chamber and lateral walls. (B) Lateral walls, 
subassembly section view 
Additionally, two lateral positioners made in AISI 316L2, secure the 
walls to the chamber and the shafts position when the system is not in 
stimulation mode (Figure 5A). These positioners are instrumental in 
holding the constructs at a certain length after they have been placed 
within the culture chamber and before the culture unit is being 
connected to the actuators by the mechanical framework.  
The shafts (AISI 316L) are rod shaped in the proximal part and have 
a square profile in the distal part to fit into the wall and to prevent the 
shaft spinning during mounting operations (Figure 5B). The proximal 
tip has been designed to couple several models of holders (or grasping 
system) in order to be compliant with more than one constructs shape. 
                                        
2 AISI 316L is a low-carbon version of the AISI 316 stainless steel, extensively 
used for many purposes due to its superior corrosion resistance, smoothness, 
biocompatibility (Hryniewicz, Rokosz and Filippi 2009) 
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A couple of medical grade silicone bellows were designed and 
fabricated ad hoc to wrap respectively the wall and the shaft (J-Flex 
rubber, UK) (Figure 5A, B). This solution prevents leakages from the 
internal part of the culture chamber allowing concurrently the 
translational motion of the shaft without introducing, for small 
displacements (5 up 10 mm), significant elastic forces or viscous friction. 
Two interchangeable types of holders (POMc) were devised to couple 
the proximal part of the shafts. The first type (Figure 6A) is able to hold 
from 3 ring shaped constructs up to 6, if two layers are superimposed 
(nominal dimension: external diameter = 16 mm, internal diameter = 9-
12 mm, height = 1-4 mm). The holder couples the shaft by means of an 
AISI 316L M3 screw. A radial bulge designed on the distal external 
profile prevents the bellows to be pulled out from the shaft motion during 
the stimulation operations. The proximal portion is the actual place 
where the constructs are placed: it is constituted by an oval base which 
holds three small rounded pillars. The second type (Figure 6B) acts like 
a standard grip and is more suitable for strip-like constructs (nominal 
dimension:, length = 15-20mm, width = 3-6mm, height = 2-7mm) 
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Figure 6: Sample holders for (A) ring-shaped, and (B) strip-like constructs 
On the upper part of the chamber, the sealing is guaranteed by the 
lid, secured to the chamber with four M4 AISI316L screws (Figure 7A, 
component 1). The lid is made out of PC and has a central circular 
optical access for the visual inspection of the constructs during the 
dynamic culture (Figure 7A, component 2). On top of it, four seats, 
radially distributed around the optical access, allow to accommodate up 
to four bayonet fitting inserts that hold the sensors for the milieu 
monitoring (Figure 7A, components 3, 4).  
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Figure 7: A, top view of the culture unit, elements: (1) lid, (2) circular 
optical access, (3, 4) bayonet fitting inserts, (5) inlet, (6) outlet and (7) cap. 
In B, lateral view, the outlet port is connected with (1) silicone compliance 
and, (2) filter 
This solution makes the sensors removable; when they are not used, 
caps with the same fitting could easily be placed instead of them (Figure 
7A, component 7). Furthermore, the chamber filling/emptying likewise 
the medium replacement is ensured by the presence of inlet (Figure 7A, 
component 5) and outlet (Figure 7A, component 6) ports3. 
In the platform here presented, the medium exchange is performed 
manually. However, the inlet and outlet ports make also possible to close 
the bioreactor within a perfusion feeding circuit for the implementation 
of an automatic recirculation of oxygenated culture medium. A perfusion 
feeding would allow to continuously perfuse the culture vessel with fresh 
                                        
3 Indeed, within any batch culture device, exhausted culture medium must 
be periodically replaced to restore the original nutrient and small-molecule 
concentrations (e.g. glucose, glutamine, grow factors, etc.) and deplete 
metabolites content (e.g. lactate, ammonia, indirectly restoring pH) within the 
culture medium. 
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medium and contemporarily remove exhausted medium to waste, 
allowing to maintain a quasi-steady culture environment.  
Female autoclavable luer locks (1/8" NPT threaded, AISI 316) were 
used for the two ports on the cap. During the standard working 
condition, the inlet port is closed with a polypropylene male luer lock 
cap while the outlet port is connected with a 100 mm high compliance 
silicone tube (Figure 7B, component 1) that houses a 0.20um pore size 
filter (Sarsted, DE) on top(Figure 7B, component 2). The presence of 
the compliance is instrumental to accommodate eventual overpressure 
created by the displacement of the actuator while the filter on top is 
instrumental to the gases exchange within the incubator.  
2.2.4 Structural Framework  
The structural framework is devised to anchor the mutual position 
between all the components of the bioreactor. In particular, it holds 
together (i) the culture chamber, which contains the constructs, (ii) the 
linear actuator, which transmits the dynamic stimulation to the 
constructs, (iii) the position transducer, for the motor position feedback 
control, and (iv) the force sensor, which senses the construct reaction 
force. It does not enter in contact with any biologic material and fulfils 
a structural function. Besides, for the actuator working at high 
frequencies (up to 6 Hz) a certain well distributed mass is required in 
order to maintain stable the bioreactor.  
With reference to Figure 8, it is composed by an anodized aluminum 
rectangular base (Figure 8, component 1) on which an aluminum sled 
(Figure 8, component 2) is screwed. The latter is the seats for the culture 
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unit and couples, on the actuation side, a permanently fixed lateral shell 
(Figure 8, component 3) which, internally, has the seat for the culture 
chamber. The contralateral right shell (Figure 8, component 4) is 
removable to allow an easy mounting of the culture unit. Externally, the 
left and right shells have, respectively, the proper seat for the linear 
actuator and the force sensor that are boxed in cylindrical holders 
(Figure 8, components 5 and 6).  
On the lateral surfaces of the holders, elliptical apertures (Figure 8, 
element 7) permit to constrain, by means of small screws, the culture 
unit shafts, respectively, to the actuator and force sensor.  
 
Figure 8: Structural framework components: (1) base, (2) sled, (3) fixed 
shell, (4) removable shell, (5) motor holder, (6) force sensor holder, and (7) 
aperture to connect the actuator with the culture unit shaft  
Unless otherwise mentioned, all the parts meant to have a hydraulic 
seat were designed according to the specification of the O-ring 
manufacturer. The chain of tolerance for the mechanical components was 
chosen according to the ISO 2768 – mH. Components were obtained by 
machine tooling by CNC systems where end-to-end component design is 
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highly automated using computer-aided design (CAD) and computer-
aided manufacturing (CAM) programs. 
Table 2 summarizes a detailed list of the material used in the 
manufacturing of the bioreactor. Components are grouped in two 
categories, i.e. those entering directly in contact with biologic materials 
and those they are not.  
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Table 2: List of materials which the bioreactor is composed of 
Components  Design Specification Selected Material 
Directly in contact with 
biological material 
 
 
Culture chamber Cytocompatibility, high 
Tg, high toughness, high 
thermal resistance T≥ 
121ºC, transparency, 
low thermal expansion 
coefficient 
Polycarbonate (PC) 
Lid 
Chamber lateral walls Cytocompatibility, high 
Tg, high toughness, high 
thermal resistance T≥ 
121ºC, transparency, 
low thermal expansion 
coefficient, good 
mechanical properties 
Polyoxymethylene 
 (POM) 
Holders 
Sensors Insert 
O-Ring 
Cytocompatibility, high 
thermal resistance T≥ 
121ºC 
Medical grade 
Silicone  
Shafts   Cytocompatibility, high 
mechanical properties, 
high thermal resistance 
T≥ 121º, corrosion 
resistance 
AISI 316L Stainless 
Steel 
Screws 
Containment bellows 
Cytocompatibility, high 
thermal resistance T≥ 
121ºC 
Medical grade silicone 
Not in contact with 
biological material 
  
Mechanical framework 
(base, sled) 
Lightness, high 
mechanical properties 
Anodized Aluminum 
Lateral shells High Tg, high toughness, 
high thermal resistance 
T≥121ºC, transparency, 
low thermal expansion 
coefficient, good 
mechanical properties 
Polyoxymethylene 
 (POM) 
Motor holder 
Force sensor holder 
Screws Good mechanical 
properties, corrosion 
resistance 
AISI 316 Stainless 
Steel, Aluminum Couplings 
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2.2.5  Stimulation and sensing unit design 
As sketched above, the stimulation and sensing unit comprises two 
distinct sub-units (Figure 9). In the next sections, firstly the design of 
the stimulation unit is detailed described. To begin, the sizing of the 
actuator and the relative power hardware was addressed; then a lumped 
model of the device was created in order to define the proper control 
architecture.  
 
Figure 9: Subunits which compose the stimulation and sensing unit 
To follow, the design and implementation of the sensing unit for sensing 
the culture and the constructs properties is illustrated.  
2.2.6 Stimulation unit design 
Mechanical stimulation devices used in Tissue Engineering 
applications, often use stepper motors to fulfil the purpose; however, 
several issues have been ascribed with the use of such actuators. Firstly, 
they have bandwidth limits that would prevent experiments with higher 
cyclic rates (frequency), and the addressing of such problems decreases 
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the mechanical displacement resolution. Additionally, such motors are 
susceptible to resonant vibrations in the range of frequencies where they 
are commonly used.  
The use of voice coil devices, whenever accurately controlled, could 
overcome these limitation. (Salazar, et al. 2015) Within the electric 
motors, voice coil actuators are electromagnetic devices which produce 
accurately controllable force over a limited stroke with a single coil or 
phase. These devices are capable of extremely high accelerations (more 
than 20g), and great positioning accuracy when suitably controlled. 
Indeed, to fulfil the given specifications, the actuation system of the 
bioreactor was designed using a voice coil linear actuator. Moreover, the 
use of a linear actuator simplifies the kinematic mechanism to produce 
the linear displacement.  
2.2.6.1 Actuation system sizing 
The GVCM-051-064-01 (Moticont, CA, USA) linear voice coil motor 
was integrated into the mechanical framework. This actuator consist of 
two separate parts; an external magnetic housing and a moving coil 
which is supplied with an internal linear bearing and shaft to support 
the moving coil.  
The actuator is able to yield a maximum continuous force of 29.7 N 
and a maximum stroke of 31.8 mm which are within the range of 
specification required for this application. As the displacement 
transducer is instrumental for the actuation of the standard control 
strategy, the ONP1-A (Gefran, BS, IT) contactless linear position 
transducer has been used. They are both integrated onto the mechanical 
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framework as illustrated in Figure 10, where the chain of transmission 
of motion between the actuator and culture unit is also described in 
detail. 
While the transducer is fixed to the base, the linear transducer 
magnetic slider is integral with the motor coil. The mutual positioning 
between the slider and the transducer body is respectful of the 
manufacturer indications.  
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Figure 10: Actuation side, chain of transmission of motion between the 
actuator and culture unit. The construct (1) is gripped by the holder (2) 
which is connected to the shaft (2).The bellow (3) tightly wraps around the 
proximal part of the holder to insulate the chamber from the outside. The 
shaft, routs along the lubricant-free bearing (4) locked on the lateral wall 
(5).The shaft is distally hollow to couple the voice coil axle (7) by means of a 
joint (8). The magnetic housing (9) of the voice coil is fixed to the holder (10). 
Underneath, the position transducer (11) is fixed to the base while the 
magnetic slider (12) is anchored to the motor coil (13). Finally a linear 
guideway (14) prevents the spinning of the coil with respect to magnetic 
housing.  
A detailed mechanical and electrical specification list for the linear 
voice coil and position transducer is reported in Appendix.  
The motor maximum continuous force versus stroke characteristic is 
depicted in Figure 11. A decrease of force at extreme strokes is observed 
from the datasheet. In such positions, the actuator coil is not completely 
linked by the magnetic field of the inner permanent magnet. Although a 
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performance decrease is expected in these conditions, the actuator is 
designed to work around mid-stroke to avoid reaching the extremes. 
 
Figure 11: Voice coil actuator characteristic  
(Moticont, GVCM-051-064-01) 
With such hardware, a power module was needed to implement the 
control architecture. If a continuous force of 30 N is considered, which 
leads to a continuous current of 3,13 A (𝑖cont =
30𝑁
9,6 𝑁/𝐴⁄ ), the NI 
9505 Full H bridge power module (National Instruments, TX, USA) was 
considered appropriate for the purpose. This device is able to drive loads 
with continuous current up to 5 A, and intermittent operation at 7.3 A. 
Furthermore, for the acquisition and conditioning of the position 
transducer output signal, the NI 9219 module (National Instruments, 
TX, USA) was chosen. Both the modules for the motor control (NI 9505) 
and the signal acquisition (NI 9219) allow a full integration with the 
cRIO NI 9075 (National Instruments, TX, USA) real-time controller 
which has been selected for the implementation of the real time 
monitoring and control of the bioreactor operations.  
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2.2.6.2 Actuation control: a lumped model of the linear actuator  
From the modelling point of view, the voice coil actuator can be 
represented with the following differential equations: 
 𝑉 = 𝐿
𝑑𝑖
𝑑𝑡
+ 𝑅𝑖 + 𝐾𝑒𝑣 Eq. 1 
 𝐾f𝑖 = 𝑚
d𝑣
d𝑡
+ 𝑐𝑣 + 𝐹 Eq. 2 
 Eq. 1 describes the electromagnetic behaviour of the device, which 
depends on the impedance parameters of the voice coil winding 
(resistance 𝑅 and inductance 𝐿) and the back electromotive force (EMF) 
constant 𝐾e. The related variables are the input voltage 𝑉, the winding 
current 𝑖 and the stroke speed of the moving parts 𝑣. 
On the other hand, the electromechanical dynamics of the system are 
governed by Eq. 2, where an input force is proportional to the current 𝑖 
by a force constant 𝐾f. Such force is then filtered by the mechanical 
lumped parameters, i.e. the mass of the moving parts 𝑚 and the friction 
losses, which, in this case, are represented as purely viscous with a 
damping 𝑐. Finally, the output force exerted to the probe is 𝐹. A 
schematics of the model is reported in Figure 12: 
 2.2 - Bioreactor description 
47 
 
 
Figure 12: Lumped model of the linear actuator; V is the voltage 
command, i is the generated current, R and L are the resistance and 
inductance respectively. E is the back electromotive force, m the mass of the 
moving part, k and c the stiffness and damping elements, q the position and 
finally F, the force exerted to the probe. 
If iron losses are neglected, the back EMF constant and the force 
constant can be assumed equivalent, and hence, defined as the motor 
constant 𝐾e ≅ 𝐾f = 𝐾m.  
A conventional cascade feedback loop control strategy was 
implemented in this case. The control consists of (1) an inner current 
feedback loop, designed as a Proportional-Integral (PI) compensator and 
(2) an outer displacement feedback loop, composed as a Proportional-
Integral-Derivative (PID) compensator (Ogata 2010). The general 
architecture is illustrated in Figure 13. 
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Figure 13: Cascade control architecture: (1) inner current feedback loop 
and (2) outer displacement feedback loop 
For the inner loop, current measurements are performed by the shunt 
resistance inside the power module, while a dedicated displacement 
transducer is required for the outer feedback loop. Noteworthy, the same 
control structure could be used also if a force control is desired, with the 
only difference of having a force transducer in place of the position 
transducer.  
In contrast with the approach followed for the inner current loop, the 
position compensator was tuned using Simulink Control Design™ 
toolbox. The PID gains were selected by observing the rise time, the 
settling time and the maximum overshoot of the closed-loop step 
response in the time domain, and the gain and phase margin of the loop 
function in the frequency domain. These values, which are inherent of 
classic control design methods (Ogata 2010), are made available through 
the tuning procedure inside Simulink Control Design™ as the control 
gains are modified.  
Furthermore, to compensate friction effects and provide effective 
mitigation of the dry friction phenomena that take place from the 
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contact between moving parts, a feed-forward loop was also integrated 
(Armostrong-Hélouvry 1991). In this case, the goal was to implement a 
non-linear law that determines the sign of the stroke rate and yields a 
constant contribution of force 𝐹0 in correspondence to the sense of 
motion. Further analytical details on the control model and position 
compensators design are reported in Appendix.  
2.2.7 Sensing unit I: culture monitoring sensors 
The bioreactor was equipped with sensors for real time monitoring 
and recording of the most critical milieu parameters i.e. pH and dissolved 
oxygen partial pressure (pO2). As already mentioned, the lid was devised 
to be compatible with up to four sensors; in fact also the carbon dioxide 
(pCO2) and temperature sensors (T) were considered to be incorporated 
in the design, even if not yet integrated in the control and monitoring 
unit. Figure 14 shows as the full configuration would appear. Selected 
sensors were all “invasive”, which means that they must be placed 
directly in contact with the culture medium bulk to obtain measurement. 
From the design point of view, sensors are inserted within the culture 
well through the dedicated inserts on the cap of the bioreactor. (Figure 
14). The inserts, allow the sealing and the holding of the sensing position. 
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Figure 14: Example of the lid equipped the full configuration of sensors. (1) 
pO2, (2) pH and (3)temperature, (4) CO2 sensors (5) bayonet fitting insert to 
hold the sensors within the culture 
Special care was devoted in selecting sensors small in size and suitable 
for standard sterilization procedures in order to avoid any contamination 
risk along the culture. For the dissolved oxygen measurement, the MI-
730 Micro-Oxygen Electrode (Microelectrodes Inc., NH, USA) was 
chosen, as an electrochemical sensor commonly used for oxygen 
measurements in biological fluids or water (namely Clark cell). The 
current produced by the redox reaction that develops inside the 
electrode, is converted in voltage, by means of an adapter serially 
connected with the sensor. With regard to the pH measurement, the 
InLabUltraMicro sensor (Mettler Toledo, ZH, Switzerland) was chosen.  
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Analog signals from the sensors were processed and digitalized by 
means of the NI 9219 acquisition module (National Instruments, TX, 
USA) The latter was embedded within the cRIO NI9075 (National 
Instruments, TX, USA) real-time controller, selected for the 
implementation of the real time monitoring and control of the bioreactor 
operations.  
A full characterization of the sensors, also to ascertain their 
sensitivity within the nominal ranges of a standard in vitro culture 
conditions (De Rossi, et al. 2004), was preliminarily carried out in a 
separate dedicate bench test, then, for each sensor, a specific calibration 
protocol has been developed according to their physical principle and to 
the manufacturer indications. After the procedures were standardized, 
they were integrated in the monitoring and control unit software, 
developed for the bioreactor operations. Indeed, in order to obtain 
reliable results, a calibration of the sensors is needed on a regular basis.  
Appendix illustrates in details the experimental set-up and 
characterization procedures.  
2.2.8 Sensing unit II: construct monitoring sensor 
To continuously monitor in real-time the mechanical properties of 
cultured tissues, the system was devised to incorporate a force sensor. 
The tissue reaction force is measured using a load cell placed outside the 
culture chamber. The tissue is located within the culture chamber where 
is clamped by the holders. It is stretched on one side from the linear 
actuator while it is held on the opposite side, which means that the force 
has to be transmitted to the force sensor through the lateral wall. Figure 
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15 describes in detail a partial section to illustrate the mechanical 
elements devised to transmit the force from the construct to the load 
cell. The machining tolerances of the pieces and the correct mounting of 
the assembly ideally guarantee the correct coaxiality, i.e. the absence of 
any torque. However, to improve the coaxiality, a lubricant-free bearing 
has been introduced. 
 
Figure 15: Force sensing chain. The passive reaction force of the construct 
(1) is transmitted to the holder (2) which is connected to the shaft (6).The 
bellow (3) tightly wraps around the proximal part of the holder to insulate the 
chamber from the outside. The shaft, routs along the lubricant-free bearing 
(4) locked on the lateral wall (5).The shaft is distally hollow and threaded to 
couple a joint (7) which fits into the left arm of the load cell (8). The latter is 
fixed to the case by means of a nut (9) 
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The load cell chosen is a XFTC300-S109 (Measurement Specialties, 
VA, USA) 10N full scale range force sensor. Special attention was 
dedicated to the insulation of the cell in order to reach sufficient 
protection level for a correct functioning within the incubator. The load 
cell measures tension and/or compression in static and dynamic 
applications. A signal conditioner, ARD154 (Measurement Specialties, 
VA, USA), boosts the signal level and increases measurement resolution 
also improving signal-to-noise ratio. Also in this case, the analog signal 
from the load cell was processed and digitalized by means of the NI 9219 
acquisition module (National Instruments, TX, USA) embedded within 
the cRIO NI9075 (National Instruments, TX, USA). 
2.2.9 Monitoring and control unit design 
In this section the architecture of the monitoring and control unit is 
described. The latter oversees (i) the feedback loop motion control 
strategy, (ii) the acquisition of the signals from the sensors and, (iii) the 
communications from and toward the user, by means of a real-time 
structure. A real-time system (which consists of software and hardware 
components) is able to reliably execute programs with very specific 
timing requirements, which is instrumental when high performances are 
required from a device, i.e. the linear actuation control.  
LabView® graphical system design platform (National Instruments, 
TX, USA), has been identified as the suitable environment to integrate 
all the requirements and in specific for the development of a (1) real-
time system for the embedded control of the stimulation unit and, (2) 
the monitoring of the sensors signals. In addition, LabView® consented 
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to develop a user-friendly software interface which allows the user to set 
and monitor the operating culture conditions. The user interface was 
requested essentially to administer tasks related to the (1) setting of a 
specific displacement/position mode or (2) receiving, processing and 
saving of the data from the sensors. 
The National Instruments hardware was considered the most 
appropriate choice for the implementation of the embedded monitoring 
and control architecture and for the compatibility with the sensors and 
the actuator. A detailed list of the technical features of the hardware 
modules, which have been used, is reported in Appendix.  
To guarantee the adequate functionality of the hardware elements 
used in the design, a host–target application architecture has been 
developed according to the scheme in Figure 16. 
 
Figure 16: host-target application architecture 
The host application, is the actual software developed with 
LabView®. It runs on the PC and executes actions with VI’s sending 
commands to the target and receiving information from it. The cRIO 
9075 (real-time processor) (National Instruments, TX, USA) is the 
target application, a platform suggested for embedded applications. 
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The architecture of Figure 16 was structured in order to parallelize two 
main processes, (1) the mechanical actuation (a bidirectional dataflow 
from host to target), and (2) the signals from sensors (a unidirectional 
dataflow from target to host) 
In detail, for what concerns the mechanical status, the software 
controls four conditions for the bioreactor: (1) the stand-by condition, 
(2) the activation/deactivation of the control status, (3) cyclic motion, 
e.g. sinus waved, square-waved and triangular waved displacement, and 
(4) the ramp displacement.  
These operational modes, were organized, within the user interface, 
in two main panels which can be selectively activated by the user i.e. (a) 
Mechanical Stimulation Panel and, (b) Characterization Panel. Controls 
and indicators allow the user to actively command and monitor the 
operations. They are composed by three main sections: (i) a status 
indicator which summarizes the current settings, (ii) an area were the 
user inputs the values and chooses settings for the action required and, 
(iii) an area where the signals form the stimulation components are 
graphed.  
In Figure 17 the Mechanical Stimulation Panel is depicted. The user 
can choose the stimulation mode, stimulation frequency and duration, 
the % of displacement as well as move backwards and forwards with a 
step of variable amplitude. On the right part, the position transducer 
displacement signal is visualized as well as the force developed by the 
motor during the motion.  
Chapter 2 –  Design and implementation of cyclic strain-based bioreactor 
56 
 
Figure 18 shows the Mechanical Characterization Panel. The user can 
move backwards and forwards with a step of variable amplitude, then 
set the slope of the ramp (mm/min) as well as the maximum 
displacement. 
 
Figure 17: Mechanical Stimulation Panel. (i) Dashed green indicates a 
status indicator which summarizes the current settings, (ii) dashed red the 
area were the user inputs the values and chooses settings for the action 
required and, (iii) in dashed purple the area where signals from the 
stimulation components are graphed 
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Figure 18: Mechanical Characterization Panel. (i) Dashed green indicates a 
status indicator which summarizes the current settings, (ii) dashed red the 
area were the user inputs the values and chooses settings for the action 
required and, (iii) in dashed purple the area where the position VS force data 
are graphed  
On the other hand, the software allows to execute actions on the 
signals from the sensors. Two main events are executed within the user 
Interface, i.e. by the host, (1) the calibration, where the signals are 
calibrated according to the experimental procedures (independently 
developed) and, (2) the visual displaying/saving of the signals  
The correspondent panel is the so called Monitoring Panel, reported 
in Figure 19. The calibration section allows to access into an interface 
specifically designed to guide the user within the calibration. 
Furthermore, the saving of the signals could be enabled by the user.  
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Figure 19: Monitoring Panel. (i) Dashed green indicates a status indicator 
which summarizes the current settings, (iii) in dashed purple the area where 
the signals from the sensing unit components are graphed 
Technically, the cRIO target system executes (1) the proportional-
integral-derivative control algorithm with the proper loop rates and 
interacts directly with the linear voice coil actuator4, and, (2) the sensor 
signal acquisition. Motion control tasks, according to the control model 
outputs, are real-time performed. Indeed, as predicted by the model, 
each level of the control architecture has to work within a specific 
bandwidth. 
These two tasks run in parallel. To correctly control the actuator and 
process the data the two loops need to be synchronized. The NI 9219 
acquisition module (Analog input module) acquires at the same time 
                                        
4 The control loop was firstly modelled and tuned in Matlab/Simulink then 
the obtained parameters were used in the LabView implementation. 
 2.2 - Bioreactor description 
59 
 
each channel. The sampling frequency is determined by the fastest 
operation that is required in the system; indeed, to actuate at high 
frequencies (up to 6 Hz), the linear position transducer analog signal 
should be consequently sampled. Also, for the load cell, to follow 
dynamically the changes in the force at high frequencies, the signal 
should be sampled with same criteria, while the other signals i.e. pH and 
pO2 have slower dynamics. Hence, the maximum NI 9219 acquisition 
module sampling frequency, 100 S/s, was considered satisfactory.  
The modules, cabling as well as the connectors from and toward the 
actuator/sensors were boarded in the so called control box. 
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2.3 Bioreactor assessment and results 
2.3.1 Units assembling and preliminary operations 
The bioreactor components were assembled together to check the 
couplings and the ease of assembling/disassembling. The mechanical 
framework was assembled and, both the motor and the position 
transducer anchored to the chassis. The mutual position between the 
transducer and its sliding element, fixed to the bottom of the coil, was 
verified.  
The culture unit was assembled separately and finally the sensors 
mounted on top by means of the dedicated inserts. The compliance was 
connected to the outlet port and a luer fitting cap on the inlet port. 
Afterwards, the culture unit was installed within the framework. On 
the “actuation side”, the concentricity and coaxiality of the motor shaft 
with respect to the culture unit shaft was also ascertained. After the 
coupling, no appreciable friction was detected in moving by hand the 
coil, which seemed to slide freely. On the “sensing side”, contralateral to 
the actuation, the load cell was fixed to the holder and clamped with its 
own joint to the culture unit shaft.  
The actuator, position transducer, the pH and oxygen sensors were 
connected to the control box by means of dedicated connectors. Finally, 
the control box was connected to the PC by means of a LAN cable. 
Preliminary controls were executed to check the correctness of the 
electrical cabling. Figure 20 shows in detail a complete view of the 
system once the components were assembled. 
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Figure 20: Culture unit installed within the mechanical framework. In the 
upper panel a perspective view of the bioreactor is represented. In the middle 
panel details on the sensing (left picture) and actuation side (right side) are 
reported while the lower panel shows the top view  
Figure 21 shows an enlarged view of the system which comprehends 
(1) the control box (2) the PC with the software for the monitoring and 
control operations.  
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Figure 21: Monitoring and control system 
The software was preliminary tested for the single subsystems, then 
the functioning of all the controls and indicators within the three main 
software panels (1) Stimulation Panel, (2) Monitoring Panel and, (3) 
Characterization Panel was ascertained.  
2.3.2 Stimulation unit tuning and assessment 
To speed up the tuning of the actuation control loops and determine the 
starting values for the Proportional-Integrative-Derivative (PID) 
compensator, a lumped control model of the actuation system was 
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implemented in MATLAB/Simulink®. The output values served as a 
basis for the control tuning in LabView®. Subsequently, the generated 
displacement and its accordance with the input reference, in terms of 
frequency and amplitude, was verified on the real system. To address 
defective reference tracking, an additional mapping gain element was 
used to adapt the output amplitude to the desired value. Next sections 
illustrates in detail these assessment operations. 
2.3.2.1 Actuation control model, simulation and results 
The lumped control model of the actuation system was implemented 
in MATLAB/Simulink®, as shown in Figure 22. Indeed after having 
implemented the control structures in LabView®, the existence of the 
model was advantageous to base the initial values.  
 
Figure 22: MATLAB/Simulink® model of the complete control system.  
This model contains the already described control architecture 
enhanced with further implementation details. The plant (actuator) is 
represented as a subsystem with one input (voltage V) and two outputs 
(current i and position q). The mechanical parameters of the plant are 
listed in Table 3. 
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Table 3: Plant parameters 
Parameters Value 
mass (g) 333,5 
viscous friction coefficient (Ns/m) 20,31 
stiffness (N/m) 50 
dry friction force (N) 3,84 
The controllers were discretized at specific sample rates to emulate 
their implementation on the LabView® hardware. The derivative action 
of the outer-loop PID was filtered to avoid infinite gains at high 
frequencies. Integral wind-up was limited using a clamping algorithm 
(Visioli 2003). Furthermore, the position feedback signal was under 
sampled and rounded to reproduce the limitations of the target 
hardware5. The feed-forward current gain (Kff) was identified by finding 
the Coulomb friction force offset of the device. The system parameters 
are summarized in Table 4.  
                                        
5 Indeed, an important aspect regards the power stage inability to realize 
infinitely small duty cycles. Minimum conduction time was taken into account 
from the manufacturer’s datasheet. 
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Table 4: Control model parameters 
Parameter Value 
DC bus voltage (V) 24 
current saturation (A) 3 
inner loop bandwidth (Hz) 500 
inner loop proportional gain (1/A) 0,223 
inner loop integration time constant (ms) 0,436 
inner loop discretization step (us) 50 
feedforward current gain (A) 0,3 
outer loop proportional gain (A/mm) 1,2 
outer loop integration time constant (s) 1,43 
outer loop derivative time constant (s) 0,02 
outer loop discretization step (ms) 10 
power stage minimum conduction time (us) 2 
For simulation purposes, the model was executed using the ode23s 
variable-step integration method with a maximum step size of 50s. This 
solver choice is suitable for electromechanical system models, which are 
usually stiff due to the presence of time constants different in orders of 
magnitude.  
A broad range of working condition have been simulated in terms of 
displacement and frequency. Nevertheless, at the present, the span has 
been limited to the range of 0.5-3mm displacement, and 1-6Hz frequency.  
Three main output values were considered significant: (1) the position 
measurement versus position reference profile (2) the current 
measurement versus current measurement profile, and (3) the voltage 
command curve. Each simulation run is characterised by the following 
parameters: 
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- Amplitude of the position reference waveform 
- Frequency of the position reference waveform 
- Reference gain used for that particular condition 
Firstly, in Table 5, the most inherent response features for the control 
system are reported.  
Table 5: Control system response features 
Parameter Value 
rise time (s) 0,02 
settling time (s) 0,66 
overshoot (%) 6,59 
gain margin (dB) 9,93 
phase margin (deg) 61,3 
For clarity of dissertation, only some working condition are presented, 
being the intermediate condition less relevant. In the figures: position 
measurement (solid, blue) versus position reference (dashed) is reported 
in the first line; current measurement (solid, blue) versus current 
reference (dashed) in the middle line while the voltage command is 
reported on the lower line. 
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Amplitude: 0.5mm, Frequency: 1Hz, Gain: 1.04 
 
Figure 23 – Amplitude 0.5 mm, 1 Hz 
Amplitude: 3mm, Frequency: 1Hz, Gain: 1.04 
 
Figure 24 – Amplitude 3 mm, 1 Hz 
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Amplitude: 1mm, Frequency: 6Hz, Gain: 1.2: 
 
Figure 25 - Amplitude 1mm, 6Hz 
Amplitude: 3mm, Frequency: 6Hz, Gain: 1.2: 
 
Figure 26 - Amplitude 3mm, 6Hz 
As expected, the gains to be used in in LabView® control tuning (1 
Hz, Gref: 1.04, 2 Hz, Gref: 1.1, 6 Hz, Gref: 1.2) are independent from the 
amplitude for two main reasons:  
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(1) The system is not in saturation which means the actuator 
doesn’t require high current and so the amplitude variation is 
not heavily affecting the voice coil performances. 
(2) There is only one non linearity implemented in the model: the 
friction which has been modelled as the contribution of the (i) 
viscous friction, and (ii) the Columbian friction. However, the 
latter is balanced by the feed-forward loop. 
The output values served for the control tuning in LabView®. 
2.3.2.2 Motion verification 
Once the system was assembled and put in standard operative 
conditions, the generated displacement and its accordance with the input 
reference, in terms of frequency and amplitude, was verified.  
The input reference of the system consists of a desired waveform 
profile to follow. During static or quasi-static testing, position and 
current errors tend asymptotically to zero due to the integral action of 
the compensators. Indeed in the actual system, during dynamic 
excitation, perfect reference tracking is not guaranteed in transient 
conditions. To address this issue, an additional mapping gain element is 
used to adapt the output amplitude to the desired value. This approach 
includes the introduction of a gain coeffient K for the PID value, and it 
is valid because there is interest in providing a specific waveform 
amplitude, disregarding of the phase lag between input and output. In 
this particular case, this mapping has to be experimentally tuned by 
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spanning the broad dynamic working range of the device and suitably 
selecting a reference gain for specific amplitude and frequency conditions.  
The generated displacement and its accordance with the input 
reference, in terms of frequency and amplitude, was verified. Starting 
from the Proportional-Integrative-Derivative (PID) values from 
simulation output (kp:0.0122; kd:0.098; ki:4e-5), the most acceptable K-
PID and Kff values were found by spanning a sub selected dynamic 
working range of the device (0.5-3mm at 1 Hz). Reference gains found 
for the specific displacement are reported in Table 6. 
Table 6: K-PID and Kff values obtained from the  
experimental mapping 
Amplitude(mm) KPID Kff 
0,5 5 3,1 
1 5 3,3 
1,5 4,6 2,9 
2 4,3 2,9 
2,5 4,25 2,85 
3 4,2 2,9 
 
The input reference and the correspondent output waveforms are 
grouped and shown in the position measurement (solid, black) vs 
position reference (dashed, black) are superimposed, the amplitude 
ranges between 0,5 and 3mm with 0,5 step increment. (Time in seconds 
on the x axis and displacement in mm on the y axis). 
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Figure 27: Input reference and the correspondent output waveforms for 
displacement in the range 0.5-3mm @ 1Hz. Time in seconds on the x axis and 
displacement in mm on the y axis 
For low displacements i.e.0.5-1mm, the actuator is able to follow the 
reference with a discrete performance. The signals appears to be regular 
in frequency even with moderate oscillations on the peak amplitudes. In 
the considered window, i.e. 10 seconds of signal, the lowest measured 
waves show an error, with respect of the nominal value of 30%, at 0.5mm 
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and 13% at 1mm respectively, while the highest peak to peak waves are 
moderately lower. Besides, the shape is not always regular. 
For higher displacements, from 1,5mm up to 3mm, the actuator is 
able to follow the reference with a better performance. The signals 
appears to be regular in frequency and even if some oscillations on the 
peak amplitudes are present, the repeatability of the signal increases. 
Errors range between 8.7 and 3.3%. 
Discrepancies found between the model and the real system are to be 
ascribed to hysteretic non-linearities which are present and too intricate 
to be included in a first approximation model. Further improvements 
can be obtained with a refinement of the mapping procedure. Besides, 
the system showed an enhanced sensitivity to the initial coil position. 
However, this latter issue is consistent with the intrinsic characteristics 
of the voice coil and can be override positioning the coil congruently. 
2.3.3 Sensing unit assessment 
2.3.3.1 pH and O2 sensors 
The pH and O2 sensor’s characterization procedures have been 
developed independently from the platform, before the system was 
completed and assembled. This approach is valid because, during 
operations, the calibration of these two sensors is done before they 
undergo to sterilization process and assembled into the lid of the 
bioreactor. A dedicated bench test has been devised for the 
characterization of each sensor. The bench was composed by: (1) the NI 
9219 (National Instrument, USA) acquisition module embedded in the 
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CompactRIO-9075 chassis (National Instrument, USA) and, (2) a PC 
where a dedicate purpose-built software interface developed in LabView 
(National Instrument, USA) allowed to acquire and record signals from 
the sensors. After the procedures were standardized, they were 
integrated in the main user interface, developed for the bioreactor 
operations.  
Sensitivity, and offset values for both O2 and pH sensors are reported 
in Appendix. Furthermore, for the pH sensor, an additional validation 
test has been carried out to ascertain the ability of the sensor to measure 
small changes of pH in a narrow range around pH 7. In the Appendix 
the procedures are firstly described, and a scheme is furnished to assist 
the user step by step in the calibration process. 
2.3.3.2 Force sensor 
The assessment of the force sensor regarded the evaluation of the 
inaccuracy in sensing that could originate by the adopted architectural 
solution. In fact, the force exerted by the constructs has to be 
transmitted from the inside of the culture unit through the lateral wall 
to the force sensor. Even if the machining tolerances and the correct 
mounting of the assembly ideally guarantee the coaxiality and the 
absence of any torque, yet, significant friction due to potential 
misalignments could be originated. 
After a preliminary calibration, tests were carried out to verify that 
the mechanical coupling between the cell and the probe (the construct 
holder) allows the correct sensing. Therefore, the ability of the sensing 
system to determine the mechanical stiffness of a calibrated 
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instrumentation spring was verified. The spring stiffness was previously 
determined using an MTS standard tester (MTS System Corporation, 
USA) equipped with a 10N full scale range load cell. A linear regression 
on the force-displacement data was carried out to calculate the slope of 
the curve in the linear region. Results from three independent tests gave 
a mean value of 0.057 ± 5.19e-5 N/mm.  
The spring stiffness was estimated in three bioreactor configurations: 
(i) load cell directly connected to the shaft, (ii) complete configuration 
including the lubricant-free linear bearing and, (iii) complete 
configuration in absence of the lubricant-free linear bearing. Figure 28 
illustrates the three configurations. 
 
Figure 28: Scheme of the testing conditions, from the top to the bottom (1) 
load cell directly connected to the shaft (2) system in the complete 
configuration including the bearing, and (3) system without in the complete 
configuration excluding the lubricant-free bearing. 
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The tests were carried out in dry condition, i.e. without any fluid 
inside the culture unit, setting in the Characterization Panel a ramp 
displacement with a nominal speed of 5mm/min and a total 
displacement of 3mm. A minimum of three independent test were run 
for each condition. Results in terms of the calculated stiffness (K: 
(N/mm)) are presented as the average ± SD, and grouped in Figure 29. 
 
 
(i) without lateral wall 
nominal stiffness, 
K=0.057±5.19e-5 N/mm 
Calculated stiffness, 
K=0.05±8.89e-5 N/mm 
 
 
(ii) complete  
nominal stiffness, 
K=0.057±5.19e-5 N/mm 
Calculated stiffness, 
K=0.028±5.94e-3 N/mm 
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(iii) without bearing 
nominal stiffness, 
K=0.057±5.19e-5 N/mm 
Calculated stiffness, 
K=0.052±9.54e-4 N/mm 
Figure 29: Characterization test configurations, from top to down: (i) 
without the later wall, (ii) complete, (iii) without the linear bearing 
In the first condition, i.e. the load cell is directly connected to the 
shaft, the mean stiffness value was: K(i)=0.050±8.89e-5 N/mm. Values 
obtained from the independent tests were overlapping, even if the 
averaged stiffness is slightly lower than the one calculated with the MTS 
system.  
In the second configuration, i.e. complete configuration, the mean 
value for the stiffness was: K(ii)=0.028±5.94e-3 N/mm. This value is 
almost the half of the nominal stiffness. Most likely, a misalignment is 
originated by imperfect coaxiality of the joint which couples the shaft 
on one side and the load cell on the other side. The bearing is over-
constraining the shaft, and consequently, if a misalignment is present a 
significant friction could follow.  
In the third configuration, carried out in the absence of the bearing, 
the calculated stiffness is: K(iii)= 0.052±9.54e-4 N/mm. Tests are 
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overlapping even if, as already observed in the first test, the mean 
stiffness is slightly lower than the one calculated with the MTS system.  
The presence of the linear bearing showed to over-constrain the shaft. 
In the absence of the bearing the value found for the stiffness differed at 
maximum 10% with respect to the real value, thus indicating that the 
system can be used in this configuration for an indicative evaluation of 
the cultured construct stiffness even if further modification could be 
required to increase the sensitivity. 
2.3.4 Sterility test and performance in incubator 
The bioreactor has been tested for sterility maintenance of the culture 
unit and the milieu sensors, in (1) static conditions and (2) during 
dynamic motion within the incubator.  
The culture unit elements were previously washed and soaked for 1h. 
Before sterilization some pieces were preassembled to reduce the 
contamination risk during the assembling procedure under the hood (the 
shaft were coupled with the construct holder and inserted within the 
lateral wall with the bellow wrapping both sides). The chamber, the 
preassembled later walls, the lid, the lid caps, the luer lock connectors, 
the compliance tube, the sensors inserts, and inlet tubing were 
independently packed and sterilized in autoclave (120ºC, 1h). 
Separately, the tip of pH and O2 sensors was carefully washed in PBS 
and then immersed in freshly PBS for 20 min. After washing, they were 
placed in a sterile 120 mm petri dish and underwent to a 20 min 
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sterilization cycle by UV under the hood. (10 min each side; turned 
meanwhile and likewise exposed to improve the sterilization process). 
After sterilization, the components were transferred under the hood and 
the culture unit assembled. Then, in sequence the following operations 
were executed: 
- The chamber was filled with standard culture medium 
(DMEM5671, Sigma-Aldrich). No streptomycin/penicillin was 
used within the medium to enhance the validity of the test. 
- The lid was mounted on top of the culture unit (A sterile filter 
was used on top of the compliance and a sterile injection site 
coupled with the inlet tubing). 
- The pH and oxygen sensors were inserted within the lid by means 
of the bayonet fitting inserts. The other two open spots for were 
closed with the dedicated caps.  
The assembly was then transferred within the incubator as shown in 
Figure 30.  
 
Figure 30: Assembly within the incubator 
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Each 48 hours 5 mL of medium were sampled by the injection site 
port with a 10mL sterile syringe and checked: (1) at a glance, to check 
any colour and/or density changes and, (2) under a standard optical 
microscope to check the presence of any bacteria or yeasts.  
After 5 days the chamber was moved under the hood and the lid 
removed to check that any contamination or yeasts aggregates were 
present in the medium bulk neither nearby of the sensors. No medium 
color change neither viscosity was observed (Figure 31).  
 
Figure 31: Medium and sensor tip status after sterility test. (A), the 
culture unit after the culture, (B) culture medium appearance and, (C) detail 
in nearby of the sensors tip. Any contamination or yeasts aggregates were 
present in the medium bulk neither nearby of the sensors 
To verify the sealing and sterility maintenance under dynamic 
condition, after 5 days of static culture, the culture unit was mounted 
on the mechanical framework and connected to the control box; a 
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sinusoidal displacement of 1,5mm at 1Hz was imparted for 1 day  
(Figure 32).  
 
Figure 32: Bioreactor within the incubator during dynamical motion 
The chamber was then removed from the chassis and replaced in the 
incubator up to 10 days. Neither yeasts aggregates nor any other source 
of contamination were found in the medium bulk or nearby of the 
sensors. 
For what concerns the overall system performance within incubator, 
the increase of temperature (from environmental 24-27ºC to 37ºC) and 
humidity (from 50-60% to 98/99%) seemed to not affect the performance 
of the bioreactor. Some condensation drops were observed on the coil 
after 6 hours of mechanical actuation without any consequence on the 
motor performance  
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2.4 Discussions and conclusions 
In this chapter the design and development of a novel advanced 
bioreactor has been presented. The proposed system is meant (1) to 
deliver native-like or pathologic cyclic strain to thick-relevant engineered 
cardiac constructs, (2) to assess their mechanical properties during the 
culture in a non-destructive manner, and (3) to monitor medium 
parameters in real time. At present, several devices have been developed 
for this purpose (Birla, Huang and Dennis 2007, Kensah, et al. 2011, 
Govoni, et al. 2014). However, tissue mechanical properties have never 
been monitored in combination with physicochemical parameters 
(Kensah, et al. 2011) and the mechanical stimulation pattern is limited 
in terms of waveforms, frequency and duty cycle, narrowing the 
strategies for applying biomimetic culture strategies (Birla, Huang and 
Dennis 2007). Additionally, current devices do not adapt the stimulation 
to the actual maturation stage of the tissue, which would turn into the 
optimization of cardiac muscle-relevant properties (Zimmermann 2013). 
The engineering solutions introduced in the design of this new cyclic 
strain-based bioreactor allow to obtain controllable displacements within 
physiological/pathological ranges (0.5-20% of strain, 1-6 Hz stimulation 
frequency). Firstly, the use of the voice coil actuator simplifies the 
kinematic mechanism to produce the linear displacement. Additionally, 
the feed-forward loop integrated in the control strategy permits to take 
into account friction effects due to the mechanical couplings and provides 
effective mitigation of the dry friction phenomena. The experimental 
tuning of the actuation control was speeded up by the lumped model 
developed in Simulink™, and the obtained assessment results show the 
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suitability of the actuator in following the waveforms imposed by the 
reference. To guarantee reference tracking in dynamic conditions, an 
additional mapping gain element was used to adapt the output 
amplitude to the desired value. At present, the mapping gain was found 
for a sub selected dynamic working range of the device (0.5-3mm at 1 
Hz) which was considered a starting point for a more comprehensive 
validation. Noteworthy, the control strategy which have been designed 
is also suitable for a force-based control if a force transducer is used in 
the control loop in place of the position transducer. 
With regards to the sensors for O2 and pH, characterization 
procedures have been established and in house tests showed a suitable 
sensitivity. 
The sensing system designed to assess the mechanical properties of 
the cultured tissues has been evaluated by means of a calibrated 
instrumentation spring. With the present configuration, the stiffness 
measured within the bioreactor differed at maximum 10% of the real 
value, thus indicating that the system can be used for an indicative 
evaluation of the elastic modulus even if further modification is required 
to increase the sensitivity. 
Finally, the sterility maintenance of the culture unit in its complete 
configuration, i.e. with the sensors within the culture chamber, was 
verified in static and dynamic conditions. Contextually, the validity of 
the sterilization procedure for the O2 and pH sensors was verified.  
Some limitations affect the bioreactor performance in the current 
configuration. From the mechanical point of view, the coupling between 
 2.4 - Discussions and conclusions 
83 
 
the actuator and the load, i.e. the engineered tissue, could introduce 
significant friction which could affect the displacement accuracy. 
Furthermore, the coupling on the “sensing side”, between the load cell 
and the shaft, could be critical. Indeed, even if the machining tolerances 
and the correct mounting of the assembly ideally guarantee the correct 
centering and the absence of any torque, friction due to potential 
uncontrolled misalignments could be originate by the thermal expansion 
and shrinkage of the components due to repeated sterilization cycles. 
Some structural modifications, involving the increase of the gap between 
sliding elements, i.e. the lateral walls and the shafts, or the design of an 
alternative coupling method, could actually mitigate the friction effects. 
Moreover, future modifications could implicate the housing of the force 
sensor within the culture chamber in order to increase the measurements 
reliability. 
As regards to the control strategy, the hardware used to implement 
the control strategy presents some limitations. During high speed 
displacements, processor frequency could be not high enough to close the 
actuation displacement loop in order to guarantee the Hard Real Time 
(HRT) determinism. A future solution could be to separate the 
monitoring of the sensors (which have a slower dynamic) from the 
actuation control, by using two dedicated modules.  
In addition, the off-line characterization of the friction (which is taken 
into account with the feed-forward loop) could be subjected to errors as 
far as the test conditions are significantly changing (e.g. humidity, 
increase of temperature, thermal dilatation of the components). In this 
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case, the implementation of an adaptive control strategy could overcome 
this limitation.  
Although these limitations, the developed bioreactor represents a 
valuable proof of concept capable, in its most advanced operational 
mode, to culture engineered cardiac constructs with a biomimetic 
approach, by monitoring both their mechanical properties and the most 
relevant culture parameters during the culture, and by providing native-
like/pathologic cyclic stretch stimulation. Furthermore, the adopted 
hardware and software architecture will allow in the future the 
implementation of an adaptive stimulation protocol in order to train the 
cultured constructs on the basis of their actual maturation stage. 
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Appendix 
Current, position and feed-forward loop compensator 
design 
As already mentioned in Chapter II, the voice coil actuator can be 
represented with the following differential equations: 
 𝑉 = 𝐿
𝑑𝑖
𝑑𝑡
+ 𝑅𝑖 + 𝐾𝑒𝑣 Eq. 1 
 𝐾f𝑖 = 𝑚
d𝑣
d𝑡
+ 𝑐𝑣 + 𝐹 Eq. 2 
Eq. 1 describes the electromagnetic behaviour of the device dependant 
on the resistance 𝑅, the inductance 𝐿 and the back electromotive force 
(EMF) constant 𝐾e. The related variables are the input voltage 𝑉, the 
winding current 𝑖 and the stroke speed of the moving parts 𝑣.  Eq. 
2 governs the electromechanical dynamics of the system, where an input 
force is proportional to the current 𝑖 by a force constant 𝐾f. The latter 
is filtered by the mechanical lumped parameters, i.e. the mass of the 
moving parts 𝑚 and the friction losses, which, in this case, are 
represented as purely viscous with a damping 𝑐. Finally, the output force 
exerted to the probe is 𝐹.  
A conventional cascade feedback loop control architecture has been 
implemented to produce accurate and controllable displacement of the 
voice coil linear actuator. Indeed, an inner current feedback loop sets the 
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current, which is proportional to the force by a force constant 𝐾f., while 
the outer loop sets the position. Furthermore, a feed-forward loop is used 
to reduce friction effects. Scheme of Figure 1 summarizes the feedback 
loop control architecture. 
 
Figure 1: Cascade control architecture and feed-forward control loop 
The inner loop: current compensator design 
The inner loop has been designed as a Proportional-Integral (PI) 
compensator. It can be tuned following an analytic approach where the 
integral time constant is used to cancel the electromagnetic pole of the 
voice coil actuator. In particular, the transfer function between voltage 
and current is simply: 
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 𝐺i(𝑠) =
𝑖(𝑠)
𝑉(𝑠)
=
1
𝑠𝐿+𝑅
 Eq. 3 
Note that the stroke speed is considered as a disturbance in this case. 
In other words, the  Eq. 3 transfer function indicates short-circuit 
operation. The compensator transfer function is: 
 𝐶i(𝑠) = 𝐾p,i (1 +
1
𝑠𝜏i,i
) Eq. 4 
being 𝐾p,i the proportional gain of the PI controller and 𝜏i,i the time 
constant. The closed-loop transfer function assuming a current feedback 
on the plant 𝐺i(𝑠) and a current reference 𝑖ref is: 
 𝐹i(𝑠) =
𝑖(𝑠)
𝑖ref(𝑠)
=
𝐺i(𝑠)𝐶i(𝑠)
1+𝐺i(𝑠)𝐶i(𝑠)
=
𝐾p,i(1+𝑠𝜏i,i)
𝑠𝜏i,i(𝑠𝐿+𝑅)+𝐾p,i(1+𝑠𝜏i,i)
 Eq. 5 
Choosing 𝜏i,i = 𝐿/𝑅 leads to the following simplification: 
 𝐹i(𝑠) =
1
𝑠
𝐿
𝐾p,i
+1
 Eq. 6 
The latter transfer function exhibits a first-order behaviour with 
unitary static gain. The frequency of its pole denotes the bandwidth of 
the controlled system. Thus, to achieve a particular actuation frequency, 
the proportional gain can be tuned according to 
 𝐾p,i = 2𝜋𝑓i𝐿 Eq. 7 
where 𝑓i is the bandwidth frequency of interest.  
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The outer loop: position compensator design 
Considering the force as an ideal input of the system (which is a valid 
assumption if the current loop, i.e. the inner loop, is tuned correctly and 
the actuator is working within the bandwidth) the transfer function 
between force and position is simply: 
 𝐺𝑞(𝑠) =
𝑞(𝑠)
𝐹(𝑠)
=
1
𝑚𝑠2+𝑐𝑠+𝑘
 Eq. 8 
Consider a generic Proportional-Integral-Derivative (PID) 
compensator 𝐶q(𝑠) with transfer function: 
 𝐶q(𝑠) = 𝐾p,q (1 +
1
𝑠𝜏i,q
+ 𝑠𝜏d,q) Eq. 9 
being 𝐾p,q its proportional gain, and 𝜏i,q, 𝜏d,q the time constants due 
to the integral and derivative actions, respectively. The closed-loop 
transfer function, assuming a position feedback on the plant 𝐺𝑞(𝑠) and 
a reference position 𝑞ref, is: 
 𝐹𝑖(𝑠) =
𝑞(𝑠)
𝑞ref(𝑠)
=
𝐺q(𝑠)𝐶q(𝑠)
1+𝐺q(𝑠)𝐶q(𝑠)
 Eq. 10 
The position compensator was tuned using Simulink Control 
Design™ toolbox. PID gains were selected by observing the rise time, 
the settling time and the maximum overshoot of the closed-loop step 
response in the time domain, and the gain and phase margin of the loop 
function in the frequency domain. These values, which are inherent of 
classic control design methods (Ogata, 2010), are made available through 
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the tuning procedure inside Simulink Control Design™ as the control 
gains are modified. 
The feed-forward loop: friction compensation 
A feed-forward loop has been implemented to reduce friction effects 
according to the scheme of Figure 1. In this case, the goal was to use a 
non-linear law that determines the sign of the stroke rate and yields a 
constant contribution of force 𝐹0 in correspondence to the sense of 
motion: 
 𝐹ff = 𝐹0 ⋅ sign(𝑠𝑞ref(𝑠))  Eq. 11 
This action provides effective mitigation of the dry friction 
phenomena that take place from the contact between moving parts 
(Armostrong-Hélouvry, 1991). 
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Sensors characterization procedures and assessment 
Different method of characterization for the sensors have been 
preliminary tested and the most suitable selected, then, for each sensor, 
a specific calibration protocol has been developed according to its the 
physical principle and to the manufacturer indications.  
pH sensor calibration procedure 
The pH InLabUltraMicro (Mettler Toledo, ZH, Switzerland) sensor is 
a combined electrode where the pH-sensitive glass electrode is 
concentrically surrounded by the reference electrode filled with reference 
electrolyte. Generally, the pH sensor is a glass electrode and its working 
principle is based on Nernst equation:  
𝐸 =
𝑅𝑇
𝑛𝐹
𝑙𝑜𝑔
𝐶1
𝐶2
 
Where:  
- E: Output voltage (mV)  
- R: Universal gas constant (8.31439 
𝐽
𝑚𝑜𝑙 𝐾
 )  
- T: Temperature (K)  
- F: Faraday constant (96495.7 
𝐶
𝑚𝑜𝑙
 )  
- n: charge of measured ion (in this case n=1)  
- C1: active ion concentration in solution 1  
- C2: active ion concentration in solution 2  
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The potential E, that is generated between two platinum electrodes, 
the pH electrode and the reference electrode, is a linear function of the 
hydrogen concentration in the solution which, by definition, gives the 
pH value. The pH electrode is the part that actually senses the pH in 
the solution. It consists of a glass shaft with a thin glass membrane at 
the end, sensitive to H+ ions. The purpose of the reference electrode, 
instead, is to provide a defined stable reference potential for the pH 
sensor potential to be measured against. Sensor characteristics are 
reported in the section Hardware datasheet. 
In order to achieve the best accuracy, a standard three point 
calibration method was considered the most appropriate for the 
InLabUltraMicro (Mettler Toledo, ZH, Switzerland) pH sensor. In 
addition, given the narrow range in which the measurements could lie 
(the pH value of the culture medium it is supposed to be approximately 
around 7,2-7,4), and to best mimic the working conditions for the sensor 
a specific validation test was designed. The changes of the solution pH 
were generated adding an acid or a base starting from a solution at pH 
7.0. These measurements were carried out also with the Hamilton pH 
sensor (Hamilton, USA) which possess nominal comparable 
characteristics with InLabUltraMicro.  
(A) Standard three points calibration 
The calibration of the pH sensor is done by using different buffer 
solutions (pH 7, pH 4,01 and pH 9,21 at 20ºC, FLUKA, Sigma-Aldrich, 
USA) with known and stable pH value. The first buffer sets the zero 
point, the second sets the slope and the calibration over the entire 
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measuring range has to be verified by means of the third buffer solution. 
In the ideal conditions, at 37 ºC the sensor sensitivity should be of -
61.46 mV/pH and show a linear characteristic in the range 0-10pH.  
Prior to calibration, an inspection procedure on the sensor is needful. 
The sensor was cleaned with double distilled water and a cotton pads, 
then the electrolyte level inside the electrode and the presence of bubbles 
in the liquid were verified. Potential bubbles inside the electrolyte were 
removed by shaking the sensor in the vertical plane. After the inspection, 
the calibration procedure, described in detail in Figure 2 starts by 
inserting the sensor first into the solution with pH 4,01, then into 
solution with pH 7 and finally in the solution with pH 9,21. An amount 
of 15 ml of the buffer solution within each 50 ml falcon is enough for the 
tip of the sensor to be completely immersed.  
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Figure 2: pH sensor calibration flow chart 
Three independent measurement sessions were realized, and five 
records for each of the three pH buffer points were collected. A linear 
regression of the averaged values has been calculated for sensor 
sensitivity and offset. Measures are the mean value of 100 points of the 
digitalized signal. For each experimental session, the time constant was 
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found to be around 5 minute, i.e. the time needed to reach a certain 
stability in the output voltage. The temperature was monitored all along 
the test by means of a digital thermometer and remained constant at 
26ºC. Values of the calibration and theoretical curves in terms of sensor 
sensitivity (mV/pH) and offset (mV) are reported in Table 1 and plotted 
in Figure 3. 
Table 1: pH-meter sensitivity and offset: theoretical vs experimental 
 Slope (mV/pH) Offset (mV) T (ºC) 
Experimental -50,65 343,38 26 
Theoretical -61,46 430,25 37 
 
 
Figure 3: pH calibration curves: theoretical vs experimental 
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(B) Validation Test: small changes in the interval 6.0-8.0 pH and 
comparison with Hamilton sensor 
Starting from a pH 7 solution (FLUKA 33643, Sigma-Aldrich, USA) 
an acid solution (HCl 1M) or a base (NaOH 1M) were added to the 
solution to test the sensitivity of the sensor to the pH increase or 
decrease. The Hamilton pH sensor and XSm pH-meter (Hamilton, USA) 
were used in this test to compare the results. Both the sensors were 
calibrated before to run the test.  
Several trials were carried out before to define the amount of acid or 
base to add at each step. For the pH decrease, 30μl of HCl 1 M acid 
were added with a 200 μl pipette in the solution at pH 7 (40 ml) and the 
mixture put under stirring for 3 minutes. In the following steps, the 
amount was increased up to 70 μl. The pH value was then measured 
with both the sensors. Similarly, for the pH increase 80μl of NaOH 1 M 
were added in the solution at pH 7 (40 ml) and the mixture put under 
stirring for 3 minutes. Also in this case the pH was measured with both 
the sensors. The temperature was monitored all along the test by means 
of a digital thermometer and remained constant at 26ºC. The number 
of the measures was not fixed a priori but chosen accordingly the 
reaching of a variation in the desired range. Values of the calibration in 
terms of sensors sensitivity (mV/pH) and offset (mV) are reported in 
Table 2. The sensors behaviour is graphed in Figure 4. 
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Table 2: InLabUltramicro pH-meter sensitivity and offset 
 Slope (mV/pH) Offset (mV) 
Decrease test -50,47 346,60 
Increase test -49,95 343,30 
 
 
Figure 4: Curves from InLabUltramicro and Hamilton ph-meters for 
decrease and increase tests 
The changes in pH of the solution, generated adding an acid or a base 
starting from a solution at pH 7.0 are closely followed. Indeed, the 
InLabUltramicro pH meter shows a good sensitivity for small variation 
of the pH. The agreement between the two sensors was evaluated by 
means of the Bland-Altman plot, which graphs the difference between 
the two measurements, i.e. variations measured with the two sensors, vs 
their average. Bland and Altman plots are extensively used to evaluate 
the agreement among two different instruments or two measurements 
techniques and helps in seeing discrepancies between the measurements 
from the two sensors.  
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Figure 5: Bland-Altman graphs of variations measured with the two 
sensors, vs their average 
The Bland-Altman graphs shows good agreement between the 
measuremenst. Differences among the measurements of the two 
instruments, except one, lies within the 95% limits of agreement, which 
are reported in the graph. The results from the test validate the sensor 
confirming its suitability in monitoring small changes of the pH within 
the culture medium. 
O2 sensor characterization procedure 
The O2 MI-730 Micro-Oxygen Electrode (Microelectrodes Inc., NH, 
USA) is a Clark cell, an electrochemical sensor commonly used for 
oxygen concentration measurements in biological fluids or water. The 
current produced by the redox reaction that develops inside the electrode 
is directly proportional to the partial pressure of oxygen. According to 
the datasheet (see the section Hardware datasheet), a liner relationship 
between input concentration of O2 and output current can be assumed. 
The sensor measures 1700 pA in air at 25 ºC; the expected current 
values in the bioreactor’s culture chamber (@ 37ºC) in a range of pO2 
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concentrations of 0,5-100% are respectively 59-1768 pA. 
(Microelectrodes). Given the phenomena dynamics, is reasonable to 
assume that the bandwidth of the output signal lies between 0 and 2 Hz 
(De Rossi, et al., 2004). Besides an adapter is used to convert the output 
current from the sensor in an analogical tension signal (1mV/5 pA 
input). 
A two-point calibration method seemed the most appropriate for the 
O2 MI-730 sensor (Microelectrodes Inc, USA) This method, according 
to the manufacturer indications, requires the use of two standard gases 
with percent values close to those of Oxygen to be measured. Common 
values used are 0% Oxygen for zeroing and 21% Oxygen (Ambient Air) 
for sloping or gain.  
Two Lightcyl-large bottles (Siad, BG, Italy) of sample gases were 
used. The bottles (1,6l, 40 bar) are composed respectively by: 3 or 18.8% 
of O2, 5 or 10% of CO2 and Nitrogen for the remaining volume 
(percentages are expressed with respect to the total volume). A pressure 
reducer for disposable bottles was also furnished to distribute the gases 
at an adjustable pressure.  
Before proceeding with calibration, the sensor were prepared, by 
checking the electrolyte level where the electrode is immersed (according 
to the datasheet it should have a minimum height of 6 mm), the absence 
of trapped bubbles near the electrode tip and the external membrane 
status.  
To decrease the calibration time, two separate calibration chambers 
filled with double distilled water (12 ml) were prepared, one for the 3% 
  
101 
and another for the sloping gas such as 18.8% of Oxygen. To set up the 
calibration chambers, gases were flushed for 30 minutes in each chamber 
to obtain a steady state oxygen level. The bubbling rate was carefully 
regulated (3 - 6 bubbles per second). Care was devoted to monitor the 
temperature. The calibration procedure is described in detail in  
Figure 6. 
 
Figure 6: O2 sensor calibration flow chart 
The calibration data were calculated on the values obtained from 
three independent experimental session. A linear regression of the 
averaged values has been calculated for sensor sensitivity and offset. 
Each measure is the mean value of 100 points of the digitalized signal. 
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The temperature was monitored all along the test by means of a digital 
thermometer and remained constant at 26ºC. Values of the calibration 
and theoretical curves in terms of sensor sensitivity (mV/%O2) and offset 
(mV) are reported in Table 3 and plotted in Figure 7  
Table 3: Oxygen sensor sensitivity and offset: theoretical vs experimental 
 Slope (mV/%O2) Offset (mV) T (ºC) 
Experimental 13.06 2.49 26 
Theoretical 16.19 0.00 37 
 
 
Figure 7: Oxygen sensor calibration curves: theoretical vs experimental 
The time constant was determined as the temporal difference from 
the immersion of the sensor tip into the sample gases and the reaching 
of the steady state. The signal was considered stable when the standard 
deviation of the averaged values was lower than 2.5mV, which 
corresponds, considering the slope of the calibration curve, to 0.2% of 
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Oxygen. Signals are obtained from three independent experimental 
session. Figure 8 shows the averaged signal value  
 
Figure 8: Averaged value of the Oxygen sensor signal 
The sensor is inserted in the calibration chamber, respectively 3% and 
18.8% when indicated by the red line, i.e. after 30 min of bubbling of the 
gases within the chambers. The blue line indicates the reaching of steady 
value which corresponds to a time constant of 30 min. 
Load cell calibration procedure and assessment 
The load cell chosen is a XFTC300-S109 (Measurement Specialties, 
VA, USA) 10N full scale range force sensor. The cell measures tension 
and/or compression in static and dynamic applications. The sensing 
element is fitted with a fully temperature compensated Wheatstone 
bridge equipped with high stability micro-machined silicon strain gages. 
A signal conditioner, ARD154 (Measurement Specialties, VA, USA), 
boosts the signal level and increases measurement resolution also 
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improving signal-to-noise ratio. The bridge supply voltage it set on 
±10V analogue output with a sensitivity of 30mV/V. It allows to adjust 
the zero and the gain and to filter the signal within a defined bandwidth. 
A detailed description of the sensor and its conditioner is reported at the 
end of the Appendix. 
According to the ANSI/ISA (1979) standard, the procedure for the 
load cell calibration is a static process were the system is used to make 
measurements of known reference values of the measurand, i.e. known 
weights (it is static because time is not a factor, the measuring system 
is allowed to reach the equilibrium prior to take a reading). The 
measurand values are incrementally increased from the low end of the 
range to the top end; then incrementally reduced to the low end; and 
the process repeated several times. That procedure furnishes linearity, 
hysteresis, repeatability, overall accuracy, maximum systematic and 
random errors parameters to complete characterize the sensor but it is 
not required to be executed on a regular base. Indeed, the load cell was 
chosen according to these characteristics and already calibrated by the 
manufacturer and a single test with 5 calibrated weights (20g, 50g, 100g, 
200g, 500g) seemed satisfactory for the purpose. That allowed to 
estimate the sensitivity and the DC offset of the signal. Values of the 
calibration and theoretical curves in terms of sensor sensitivity 
(mV/mN) and offset (mV) are reported in Table 4 and plotted in  
Figure 9. 
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Table 4: Load cell sensitivity and offset: theoretical vs experimental 
 Slope (mV/mN) Offset (mV) 
Experimental 0.51 24.54 
Theoretical 0.50 0.00 
 
 
Figure 9: Load cell calibration curves: theoretical vs experimental 
In the following, the datasheet of the pH, O2, load cell sensors, voice coil 
motor and the linear transducer are reported. Lastly, a brief description 
of the National Instruments hardware is given and a datasheet for the 
most relevant characteristics is included. 
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GVCM-051-064-01 linear voice coil and ONP1A linear position 
transducer 
DEVICE PARAMETER VALUE 
   
 
continuous force 32,9 N 
force constant 9,6 N/A 
back EMF 
constant 
9,6 V/M/S 
stroke 31,8 mm 
coil resistance  3,9 Ohms 
coil inductance 
@ 1000Hz 
1,6 mH 
max continuous 
power  
36 W 
linear bearing 
type 
recirculating 
balls 
   
 
measurand displacement  
max acceleration 100 m/s2 
resolution Infinite 
working 
temperature  
-20  +75ºC 
coefficient of 
temperature 
≤0,01% fs/ºC 
output signal  0,1-10,1 V 
nominal power 
supply  
24±20% 
output load  ≥10 KΩ 
protection  IP65 
max stroke  50 mm 
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InLabUltraMicro pH sensor 
DEVICE PARAMETER VALUE 
 
type of sensor  
pH Glass 
electrode  
reference electrodes type  Ag-AgCl  
type of measure   Invasive  
dimensions  
Shaft 
diameter: 
3 mm  
Shaft 
length:40 
mm  
sterilization   UV  
Output Voltage  
measure range  
From 0 to 
11 pH  
zero point   7 ±0.25 pH  
slope  
-58.16 mV 
at 25ºC  
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O2MI-730 Micro-Oxygen Electrode sensor and O2-ADAPT Oxygen 
Adapter 
DEVICE PARAMETER VALUE 
 
type of sensor Clark cell 
reference electrode type Ag 
type of measure Invasive 
depth of immersion 0.1 mm 
dimensions Body and 
tip: 3mm 
Total 
length: 86 
mm 
Lead length: 
2 m 
sterilization UV 
sterilizable 
Output Current 
response range 0 to 100% 
sensitivity 1700 pA in 
air at 25°C 
response time 20 s 
    
 
size 28.5 mm x 
22.4 mm x 
58 mm 
output 1mV/5 pA 
Input 
connectors LEMO 
00.250 
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XFTC300-S10 Load cell and ARD154 signal conditioning system 
DEVICE PARAMETER VALUE 
   
 
full scale range 0-10N 
resolution Infinite 
excitation 10Vdc 
signal output 100mV 
offset ≤ ±10mV 
linearity + 
hysteresis ≤ ±0,5%FS 
operating 
temperature 
-40ºC to 
+120ºC 
Compensation 
temperature 
0ºto 60ºC 
cable output 
2m of Ø2mm 
Teflon jacket 
cable 
   
 
input voltage 24 Vdc 
bridge impedance 120-1000Ω 
bridge excitation 5Vor 10V 
Adjustable 
sensitivity range 
0,1 to 30mV/V 
Calibration push-
button 
0,1 to 10mV/V 
Accuracy 0.01% FS 
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cRIO-9075 Integrated 400 MHz Real-Time Controller and LX25 FPGA 
The cRIO-9075 integrated system combines a real-time processor for 
deterministic processes and a reconfigurable Field Programmable Gate 
Array (FPGA) within the same chassis for embedded machine control 
and monitoring applications. It integrates a 400 MHz real-time processor 
with an FPGA and has four slots for NI C Series I/O modules. Details 
are reported in Table 5. 
Table 5: NI cRIO-9075 real-time controller characteristics 
DEVICE PARAMETER VALUE 
 
Product family 
Real time 
controller 
Number of 
Slots 
4 
Integrated 
Controller 
400 MHz 
real-time 
Input Voltage 
Range 
9 V - 30 V 
Power 
Consumption 
15 W 
FPGA 
Spartan-6 
LX25 
NI 9219, Universal Analog Input Module 
The NI 9219 is a 4-channel module designed for measuring several 
signals from sensors such as strain gages, resistance temperature 
detectors (RTDs), thermocouples, load cells, and other powered sensors. 
It can be embedded in the CompactRIO chassis. The channels are 
individually selectable, in order to perform a different measurement type 
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on each of the four channels. Measurement ranges differ for each type of 
measurement and include up to 60 V for voltage and 25 mA for current. 
Details are reported in Table 6. 
Table 6: NI 9219 signal acquisition module characteristics 
DEVICE PARAMETER VALUE 
 
Product family 
I/O signal 
conditioning 
Measurement Type 
Current, Voltage, 
RTD 
Sampling frequency 100S/s/ch 
Differential channels 4 
Analog input 
resolution 
24 bits 
Accuracy 271 µV 
Range -0.125 V - 0.125 V 
NI 9505 Full H-Bridge Brushed DC Servo Drive Module 
The NI 9505 C module for NI CompactRIO is a full H-bridge servo 
motor drive for direct connectivity to actuators such as fractional 
horsepower brushed DC servo motors, relays, lamps, solenoids, and 
valves. The configurability and performance of the field programmable 
gate array (FPGA), make it suitable for creating intelligent and efficient 
control systems using the NI LabView® graphical system design 
platform. The NI 9505 delivers continuous current of up to 5 A at 40 
ºC (or 1 A at 70 ºC) at 30 V. Details are reported in Table 7. 
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Table 7: NI 9505 power stage module characteristics 
DEVICE PARAMETER VALUE 
 
Product family Motion Drive 
Inductance Range 
500 µH - 1000 
mH 
Quadrature / Incremental 
Interface 
Direct 
Connect 
Maximum quadrature 
frequency 
5 MHz 
Continuous current 5 A 
 
  
Chapter 3  
Effects of cyclic strain on maturation, 
contractility and mechanical properties of 
Engineered Cardiac Tissues. A proof of 
concept. 
3.1 Introduction  
In the past years, significant advancements were made in the 
generation of 3D Engineered Cardiac Tissues (ECT) used as functional 
in vitro models for drug screening or investigating fundamental 
mechanisms (Vunjak-Novakovic, et al., 2014; Hirt, et al., 2014). These 
so far experiences collectively suggest that the use of suitable scaffolds 
as support for cells and the application of physiological physical signals 
(e.g. electrical and mechanical stimuli) are instrumental in achieving the 
appropriate structural rearrangement and maturation of the cardiac neo-
tissue (Vunjak-Novakovic, Tandon, et al. 2010, W. Zimmermann, 2013).  
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Many types of biomaterials have been investigated for cardiac 
engineering, from synthetic to natural ones, resembling some key 
component of the native extracellular matrix (Govoni, et al., 2013). 
Among all the investigated materials, numerous advantages have been 
highlighted for the use of hydrogels, which allow a high seeding efficiency 
and homogenous cell distribution by gelation entrapment, eventually 
minimizing loss of cells. (Jockenhoevel, et al., 2001 ). 
In particular, fibrin gels have some advantages over other hydrogel 
types, such as been easy to be injected, tunable for stiffness and 
structure, biocompatible, FDA approved and already widely use in the 
clinic routine. Moreover, the timing of the reaction can be easily adjusted 
by altering the ratio of thrombin to fibrinogen or the ratio of calcium to 
thrombin allowing the creation of various geometries. (Yuan, et al., 
2011). Polymerisation and degradation of the fibrin gel is manageable 
and can be tuned to the tissue development by using of the protease 
inhibitors, such as aprotinin and tranexamic acid (Cholewinski, et al., 
2009). Besides, the compact cell-seeded structure that results from 
gelation provides an adequate hardness for mechanical loading (Mol, et 
al., 2005). 
Improved cardiac tissue structure and higher force development have 
been observed in fibrin based engineered constructs that were exposed 
to cyclic stretch by motorized stretching devices (Birla, et al., 2007; 
Morgan & Black III, 2014; Salazar, et al., 2015) or those cultured in 
auxotonic conditions (Hansen, et al., 2010). To this purpose, several 
bioreactors have been developed and used to provide controlled 
mechanical stimulation during culture in order to promote the 
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development of cardiac engineered constructs and address their 
phenotype. (Akhyari, et al., 2002 ; Birla, et al., 2007; Morgan & Black 
III, 2014; Salazar, et al., 2015). Yet, the optimal mechanical stimulation 
strategy has not been extensively explored (Salazar, et al., 2015). Indeed, 
most of the culture platforms were meant to passively apply a time- 
constant or variable stimulus predefined by the user regardless of the 
continuous changes of the maturing ECT during the time of in vitro 
culture.  
In the previous chapter we described a novel bioreactor design, 
capable in its most advanced operational mode to (i) apply native-like 
or pathologic stimuli (namely cyclic strain), (ii) monitor in real-time 
both the milieu parameters (e.g. oxygen tension, pH) and the progress 
in mechanical stiffness of the mm-scale ECT, eventually adapting the 
stimulation to their actual maturation stage.  
As a proof of concept and towards the final validation of the 
bioreactor potential we first assessed its feasibility in generating 
functional and mature ECT. To this purpose, fibrin-based, ring shaped 
ECTs were generated and cultured within the bioreactor. The effects of 
cyclic strain on the maturation, alignment, modification on the elastic 
properties and contractility of ECTs were assessed by means of histologic 
assessments, mechanical testing and response to external electrical 
pacing along the culture.  
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3.2 Material and Methods 
The bioreactor based platform (described in detail in Chapter II) has 
been tested for suitability in culturing and delivering mechanical cyclical 
stimulation to 3D fibrin-based, ring shaped ECT. As summarized by the 
schematic experimental outline (Figure 1), neonatal rat cardiomyocytes 
were embedded in a fibrin gel and the so generated constructs were pre-
cultured for 5 days in static condition and transferred into the bioreactor 
to be subjected to cyclic mechanical stimulation for additional 4 days 
(10% strain at 1 Hz). In parallel, control engineered ring-tissues were 
cultured statically for 9 days. Tissue organization, composition, 
maturation, mechanical and electrical functionality were assessed at 
different time culture points.  
 
Figure 1 – Outline of the experimental plan 
3.2.1 Generation of fibrin-based cardiac tissues (ECTs) 
Freshly isolated neonatal rat cardiomyocytes were embedded in a 
fibrin gel at a density of 18x106 cells/ml (Vunjak-Novakovic, et al., 
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2010); 23.0 µl1 of aprotinin (3000 KIU/mL, Sigma) (Centola, et al., 2013) 
and 115.7 µl of CaCl2 (40mM) (Cholewinski, et al., 2009) were mixed 
with 10 µl of thrombin (2.5U/mL final, or 0.1 U/mL thrombin solution 
per mg fibrinogen, Sigma) (Centola, et al., 2013; Hansen, et al., 2010; 
Morgan & Black III, 2014) and the solution was transferred into a 
custom silicone mold (Figure 2A), able to cast up to three ring shaped 
constructs (ring dimension: external diameter = 16 mm, internal 
diameter = 10 mm, height = 3 mm, approximately equivalent to a 400 
µL of solution). In parallel, the cells were suspended in 150 µl of high 
glucose (4.5 g/L) culture medium (DMEM), supplemented by 1% FBS, 
1% Pen/Strep, 1% L-glutamine, 1% Hepes and mixed with 99.5 µl of 
fibrinogen (25 mg/mL, Sigma) (Hansen, et al., 2010; Morgan & Black 
III, 2014). Hydrogels were obtained by pouring the cell-fibrinogen 
solution within the mold, already containing the thrombin mix (Hansen, 
et al., 2010). After complete hydrogel polymerization during incubation 
at 37ºC for 45 minutes, the rings were removed from the molds, placed 
into a 6 well plates (Figure 2B) and 4ml/well culture medium was added 
and incubated again in 37ºC, 5% CO2 and 21% O2 humidified incubator.  
                                        
1 Quantities in µl for one construct. 
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Figure 2: ECTM cast within the custom silicone mold (A) polymerized 
ECTM after removal from the mold (B). 
Constructs were cultured for 5 days in static condition (Zimmermann, 
et al., 2000; Radisic, et al., 2004) followed by cyclic mechanical 
stimulation (10% strain at 1 Hz) for 4 days. Control engineered ring-
tissues were cultured statically for 9 days. The culture medium consisted 
in low glucose (1g/L) DMEM (Gibco), supplemented with 10% FBS, 1% 
L-glutamine, 1% Hepes, 1% Penicillin/Streptomycin and was changed 
twice a week. At day 3, tranexamic acid (tAMCA, Sigma) at a 
concentration of 160 g/mL, was added in each well in order to delay 
fibrin gel degradation (Cholewinski, et al., 2009).  
Bioreactor assembly and ECT mechanical stimulation 
After 5 days of pre-culture, samples were transferred into the 
bioreactor and underwent to cyclic mechanical stimulation for additional 
4 days. At day 5, the culture unit were assembled and the samples placed 
within the culture well. 
To prepare the bioreactor under sterile condition, some pieces of the 
culture unit were preassembled and packed for sterilization, to reduce 
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the contamination risk during the assembling procedure. Indeed, for each 
side, the shaft was coupled with the construct holder and inserted within 
the lateral wall while the bellow was wrapped at both sides. The 
chamber, the pre-assembled later walls, the lid, the lid caps, the luer 
lock connectors, the compliance tube, and inlet tubing were 
independently packed and sterilized in autoclave.  
The culture unit was assembled and the constructs transferred within 
the culture chamber under a laminar flow tissue culture hood. The series 
of images of Figure 3 shows the steps in sequence: 
i. The left and right sub-assemblies composed by the lateral walls, 
the shafts, and the bellows were inserted in the culture chamber. 
This very first step allows to put in place the construct holders 
and to laterally seal the chamber (Figure 3A). The steady, 
nominal distance between the construct holders was 11.5 mm. 
Preliminary assessments suggested that this was the appropriate 
distance to ease the placement of the engineered constructs, 
aligning them according to the stretching direction avoiding to 
preload them. Besides, this distance was appropriate to assess 
the displacement once the culture chamber was connected to the 
mechanical actuator. The position of the shaft was maintained 
fixed by the two lateral position screws. 
ii. The lid was leaned on top of the culture chamber, the inlet port 
connected to the inlet tube, closed at the opposite site with an 
injection site. The outlet port was connected to the compliance 
tube which was closed with a filter (2 μm) at the opposite site. 
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The four spots for the sensors were closed with the caps. Once 
completely assembled, a 200 mm petri dish was used to 
temporarily place the lid (Figure 3B). 
iii. The chamber was filled with 50mL of culture medium 
(maintained at 37ºC) supplemented with tAMCA. Six ECTs 
were located between the two opposite pins (two constructs per 
couple of pins) as depicted in Figure 3C. Further 35mL of culture 
medium were added to reach a total of 85mL. The lid was 
screwed on top of the chamber. In this configuration the culture 
unit is a sterile closed system and can be moved out from the 
hood into the incubator (Figure 3D).  
iv. The culture unit was connected to the mechanical framework 
directly inside the incubator (Figure 3E). The “actuation side” of 
the culture unit was attached to the actuator by means of the 
dedicate joint and the relative position-screw whose function was 
to hold fixed the holder. The initial distance of 15 mm between 
the coil and the magnetic housing was chosen as the most 
suitable for the voice coil and for having the best range of 
performance for the linear actuator. 
 3.2 - Material and Methods 
121 
 
 
Figure 3: Assembling of the culture unit under sterile condition (A), 
prefilling with the culture medium (B), construct location between the holders 
pillar (C), completion of the filling up of the culture chamber with medium 
and placement of the lid (D), connection of the culture unit to the mechanical 
framework inside the incubator (E) and setting of the stimulation parameters 
via the dedicated software (F). 
Initial settings and stimulation parameters were settled via the 
purpose-built software (Figure 3F): a pretension of 1 mm was imposed 
as minimum preload. At the beginning a sinusoidal strain with a 
frequency of 1Hz and amplitude of 8% of the initial length (12.5mm) was 
applied. Subsequently, the pretension was manually adjusted day by day 
to guarantee a constant 10% strain amplitude. Twenty five percent of 
the total amount of the culture medium present in the bioreactor was 
changed on day 3.  
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3.2.2 ECT characterization 
3.2.2.1 Histological Evaluation  
The cell distribution and morphological data on tissue development 
and organization were assessed by means of hematoxylin and eosin 
(H&E) staining on samples slices. The most relevant cardiac markers 
such as sarcomeric α-actinin, Troponin I and Connexin 43 were identified 
by immunofluorescent analysis. The presence of cardiac fibroblasts and 
the cell proliferation were assessed by using anti-Vimentin and anti-ki67 
antibodies, respectively. 
For histology, one half of each cultured ring was fixed for 1 h in 1.5% 
paraformaldehyde followed by a treatment with 30% sucrose solution 
overnight. The so fixed scaffold was then further divided in two halves 
then embedded in OCT (CellPath, UK), orienting each part through 
either the central transverse or the longitudinal cross section and 10-14 
µm thick sections were cut by means of a micro-cryostat (Microm 
International GmbH, Germany).  
Sections were stained with hematoxylin and eosin (H&E) according 
to standard protocols. Colour images were acquired with the Olympus 
BX63 microscope (Olympus, Switzerland). For fluorescence images, 
sections were tri-labeled for DAPI (to identify nuclei), cardiac troponin 
I (cTnI), and Connexin 43 or also quad-labeled for DAPI, sarcomeric α 
actinin (α-actinin), Vimentin and ki67. 
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Construct sections were incubated for 1 h in 0.3% Triton X-100 and 
2% normal goat serum in PBS, and then for 1 h in the following primary 
antibodies: (a) mouse monoclonal anti-Cardiac Troponin I (Abcam) and 
(b) rabbit polyclonal anti-Connexin 43 (Millipore ab1728) at 1:100 or (c) 
mouse monoclonal anti-sarcomeric α actin (Abcam), (d) rabbit 
polyclonal anti-Ki67 (Abcam), and (d) goat polyclonal anti-Vimentin 
(Abcam) at 1:100. Subsequently, tissue sections were incubated in the 
dark for 1 h in fluorescently labelled Alexa488, and Alexa647 anti-mouse 
and anti-rabbit (Invitrogen) or Alexa488, Alexa 546 and Alexa647 anti-
mouse and anti-rabbit and anti-goat (Invitrogen) secondary antibody at 
1:200. Nuclei were stained using DAPI (Invitrogen) at 1:150 for 1 h. 
Antibodies were diluted in 0.3%Triton X-100 and 2% normal goat serum 
in PBS. Fluorescent images were taken with an Olympus BX63 
microscope (Olympus, Switzerland) while confocal images were taken 
with a Zeiss LSM 510 microscope. 
3.2.2.2 DNA quantification 
The quantification of DNA was used to (i) assess the cell amount and 
to (2) normalize values of the collagen content; was quantified by the 
CyQUANT®Cell Proliferation Assay (Invitrogen). Each sample was 
weighed and digested overnight at 57ºC in 500µL of proteinase K 
solution (1 mg/mL proteinase K, 50mM TRIS, 1mM EDTA, 1mM 
iodoacetamide, and 10mg/mL pepstatin-A; Sigma–Aldrich) in double 
distilled water or potassium phosphate buffer (Sadr, et al., 2012). 
Working solutions were prepared according to the manufacturer’s 
protocols. The analyses were carried out measuring fluorescence with a 
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SpectraMax Gemini XS Microplate Spectrofuorometer (Molecular 
Devices, USA). The excitation and emission wavelengths used were 485 
and 583 nm, respectively. Each sample was measured in triplicate. 
3.2.2.3 Collagen quantification - Hydroxyproline assay 
Quantification of the collagen content within the ECT, was carried out 
with the hydroxyproline assay. After digestion in proteinase K (the same 
used for the DNA quantification),  samples were mixed with equal parts 
with 12M HCl, hydrolyzed at 120ºC for 24h and then dried (Cigan, et 
al., 2013). Samples were mixed with 50 µL buffered chloramine T reagent 
(63.5 mg of chloramine T dissolved in 1 mL water, and then diluted with 
1.5mL n-propanol and 2.5 mL acetate-citrate buffer (pH 6); made fresh 
daily) and incubated for 20 min at room temperature. Then, further 50 
µL dimethylaminobenzaldehyde (DMAB) solution mixed with perchloric 
acid were added (0.45 DMAB in 2 mL n-propanol and 1 mL perchloric 
acid 20%). The ratio of hydroxyproline to collagen mass was assumed as 
1:10. The mixture was heated for 20 min at 60ºC, cooled, and the 
absorbance determined at 550nm. The hydroxyproline concentration was 
determined from a standard curve (stock solution of hydroxyproline: 
1mg/mL) (Hofman, et al., 2011) 
3.2.2.4 Electrical functionality 
The ECT contractile function was assessed by evaluating the response 
to the external pacing. The Excitation Threshold (ET) and Maximum 
Capture Rate (MCR), defined respectively as the voltage at which 
constructs are observed to beat synchronously and the maximum pacing 
frequency for synchronous contraction (evaluated using voltage of 2 
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times the ET), were determined (Radisic, et al., 2004). Furthermore, 
video analysis of constructs under stimulation was performed to 
determine the regularity and frequency of contractions. 
At day 5 and 9, the contractile function of the samples was evaluated 
by monitoring spontaneous beating and contractile activity upon 
electrical stimulation at 2X/4X magnification using a bright field 
microscope (Olympus), keeping the temperature constant at 37ºC. Each 
construct was placed in a Petri dish filled with 5 mL of medium and 
containing two carbon rod electrodes (Figure 4A, B), which were 
connected to a custom built electrical stimulation system (Figure 4B, C) 
(stimulation frequency range=0-10 Hz, stimulation amplitude= 2-6 
V/cm and pulse duration=0-10 ms).  
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Figure 4: Stimulation chamber (A), 37ºC controlled atmosphere Olympus 
microscope (B), custom built electrical stimulator (C) 
Stimuli (rectangular pulses, 2ms duration) were applied at a rate of 
1Hz starting at the 1.0 V amplitude. Different spots of the constructs 
(n= 3, 4) were analysed: the voltage amplitude was increased in 0.5 V 
increments till to reach the ET. The MCR, was determined using the 
voltage set at 2 times the ET by increasing the stimulation frequency in 
0.1 Hz increments, until the paced contractions became irregular or 
desisted at all. Each stimulation sequence was digitally recorded (fps=20 
up to 40). Video images recorded during the pacing were analysed in 
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ImageJ 1.47 software (Research Service Branch, NIH). Video frames 
(Figure 5A) were scaled according to the magnification, a threshold to 
quantitatively operate on the images, and a selection to highlight the 
construct and its surrounding space of movement during the contraction 
was defined (Figure 5, B).  
 
Figure 5: Assessment of the contractility under pacing in ImageJ 1.47 
software. Frame of the video during pacing (A) and, delimitation of the region 
of interest (B). 
The centre of mass coordinates were used to calculate the 
displacement of the selected area throughout the frames, which was then 
normalized to the position of the first frame, as follows: (𝑑𝑖 =
√(𝒙𝟐 − 𝒙𝟏)𝟐 − (𝒚𝟐 − 𝒚𝟏)𝟐). Subsequently, the so obtained signal was 
used to (1) qualitatively show whether the ring follows the pacing and 
(2) eventually calculate the power spectral density (PSD) of the signal 
to assess the dominant frequency. 
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3.2.2.5 Mechanical properties: uniaxial tests 
ECTs have been tested for elastic properties by determining the Young 
Modulus (E); initial length L0 and cross sections (A1, A2) were measured 
with a digital caliper. The rings were hooked in a Microbionix (MTS 
System) using a 2N load cell and tensioned till an initial load of 0,02N 
was reached. A series of 10 cycles each of 0-10% strain at 0.1 Hz were 
performed, then the rings were stretched to failure at a rate of 5 
mm/min. The engineering stress and strain were calculated as force 
divided the initial cross-sectional area (sum of the two areas on the 
opposite branches A1, A2) and the ratio of the change in length (L – L0) 
and the original length (L0). The Young Modulus (E) was calculated by 
linear regression of the stress-strain curve in the range of 0-30% 
elongation.  
3.3 Results 
3.3.1 Feasibility of the bioreactor-based culture of ECTs 
The bioreactor suitability for culturing and delivering mechanical 
cyclical stimulation to 3D mm-scale cardiac-like tissues was verified. The 
assembling procedure, including the placement of the ECTs resulted to 
be easy and not time consuming. Indeed, time and changing of 
temperature could actually be an issue in handling cardiac tissue 
surrogates (Schaaf, et al., 2014). The culture system resulted to be free 
of bacteria/virus contamination during the entire dynamic stimulation 
period for all the conducted experiments. Changes in temperature (from 
environmental 24-27ºC to 37ºC in the incubator) and humidity (from 
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environmental 50-60% to 98/99% in the incubator) seemed to not affect 
the long term performances of the voice coil actuator or the displacement 
sensor which. A not significant difference in peak to peak amplitude was 
observed only at the beginning of the stimulation while the temperature 
of the system reached the incubator environment temperature (37ºC). 
Therefore, a slight adaptation of the control parameters, in terms of K-
PID (the additional gain implemented to modulate the Proportional-
Integrative-Derivative compensator contribution), was needed to restore 
the nominal peak to peak amplitude. Even if some condensation drops 
formed on the surface of coil after 6 hours of mechanical actuation, the 
motor performance was not impaired. 
3.3.2 ETCs remodeling along culture 
The initial size of the engineered tissues was reproducible, but varied 
during the culture time. In static condition, we observed a significant 
shrinkage, whereas in the dynamic culture the cell-based construct 
maintained a similar size, but the fibrin gel appeared strongly remodelled 
(Figure 6). The ring cross section changed in shape and dimension: from 
an initial square-shape (~9 mm2) to a circular-shape (~0.79-1 mm2 for 
dynamic or ~3.5-4 mm2 for static condition). 
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Figure 6: ECT initial size (a) and after 5 (b) or 9 (c) days in static 
condition (c) and after 9 days of culture in dynamic condition (d). 
In previous experiments, dedicated to the optimization of culture 
parameters, we found out that no tAMCA supplementation in the 
culture medium resulted in the quick degradation of the constructs (data 
not shown). 
Representative images of the samples stained for H&E at day 1 
showed that cells were similarly present in the border and the center of 
the generated constructs, suggesting a uniform spatial cell distribution 
within the entire scaffold (Figure 7A). Regarding the cell morphology, 
cardiomyocytes encapsulated in the fibrin gel initially appeared 
round-shaped. After 5 days of static culture, constructs slightly shrank 
in size, but this didn’ t result in any significant difference in cell 
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distribution along the border or in the centre of the construct compared 
to 1 day after encapsulation (Figure 7A).  
DNA quantification, normalized to the sample weight, confirmed the 
qualitative observation, showing no significant difference in the amount 
of cells between day 5 and day 1 (Figure 8). 
As opposed to static controls, at day 9, after four days of dynamic 
stimulation, samples showed a significant remodeling of the tissue along 
the border where the majority of the cells showed an elongated 
morphology, aligned with the construct edge (Figure 7B). Stimulated 
engineered tissues showed a superior extracellular matrix deposition and 
cell density at the border zone (within the first 50-200 µm-from the 
edges). For the majority of the samples, this improved organization was 
observed only on one side of the longitudinal cross section. For static 
controls, cells were mainly still round shaped and scarce matrix was 
deposited. No significant histological difference was noticed between the 
border and the centre of the static constructs. 
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Figure 7: H&E stained sections of samples cultured for 1 or 5 days in un-
stimulated condition (A) and further culture up to 9 days in static or dynamic 
culture (B). Representative images of the border (left) and the center (right) 
of the constructs (longitudinal cross sections used) are shown (scale bar 
100µm). 
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At day 9, in both static and dynamic conditions, the DNA amount 
drastically dropped almost 5 folds compared to day 5 (Figure 8). The 
cellular loss along the culture could be ascribed to the shrinkage and 
remodeling. However, as further analysis on the quantification of the 
DNA amount within the culture medium are needed to clarify this 
aspect. 
 
Figure 8: DNA content normalized to the dry weight at days 1, 5 and 9 for 
dynamically stimulated constructs and static controls 
3.3.3 Cardiac maturation 
Cardiomyocyte maturation and syncytia formation were assessed by 
late mature cardiac markers, as cardiac troponin I (cTnI), which is a 
contractile protein present in the mature sarcomeres, and Connexin 43 
(Cx43), which is the most predominant electrical gap junctional protein.  
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Figure 9: ECT cardiac maturation. Immunohistology staining for cell 
nuclei (DAPI, blue), Cx43 (red) and cTnI (green) of either  mechanically 
stimulated constructs at low (a)or high (c) magnification and of static control 
(b). Scale bar 30µm. In the high magnification (c) of the dynamic condition 
the red arrows indicate the Cx43. Scale bar 10 µm 
 
In stimulated ECTs, most of the cardiomyocytes close to the edges 
(up to 30-100 µm from the border) showed an elongated morphology 
with a cardiac troponin I structure and organization which is typical of 
mature sarcomeres and were longitudinally oriented, aligned towards the 
direction of the applied strain (Figure 9a, c). 
In addition, cardiomyocytes appeared to be electrically coupled by 
the expression of functional gap junctions (Cx43), predominantly in-
betweens neighbouring cells. In static condition, instead, cardiomyocytes 
showed preferentially a round shaped morphology and no mature 
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structures were found. Cells appeared to be mostly isolated, not 
connected and immature cells both at the edge and in the center of the 
static controls (Figure 9b).  
The presence of cardiac fibroblasts and cell proliferation was assessed 
by distinguishing cardiomyocytes, expressing sarcomeric α actinin (α-
actinin), a protein associated with z-discs that defines cardiac muscle 
sarcomeres, fibroblasts (vimentin-positive cells) and proliferating cells 
(positive for Ki67).  
In dynamic condition, ECTs were characterized again by a well-
organized network of elongated and longitudinally oriented 
cardiomyocytes, which showed α actinin positive striations characteristic 
of mature cells. 
Cardiac fibroblasts positive for DAPI and Vimentin and negative for 
α-actinin were found in both dynamic (Figure 10a) and static condition 
(Figure 10b). In the dynamic condition fibroblasts were present in 
superior number and were mainly present at the edges, surrounding the 
organized cardiomyocytes. 
Furthermore, in the dynamic condition more proliferating fibroblasts 
were found compared to static controls. The further investigation on the 
possible differentiation of fibroblasts into myofibroblasts is still ongoing. 
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Figure 10: Confocal images of ECTs stained for cell nuclei (DAPI, blue), α-
actinin (green), Vimentin (red) and ki67 (cyan)of  (a) mechanically stimulated 
constructs and (b) static control at 40x magnification (scale bar 30µm). The 
areas within the white squares in (a) and (b) are enlarged respectively for 
dynamic in (c) and for static conditions (d) at 100x magnification (scale bar 
5µm). 
3.3.4 Electrical functionality 
At day 5, ECTs did not spontaneously beat. If electrically stimulated, 
they responded to stimulation showing an Excitation Threshold (ET) of 
7.2±3.3 V/cm and a maximum capture rate (MCR) of 5.0±2.1 Hz (Figure 
11). The signals processed from the video analysis during stimulation at 
1Hz showed an asynchronous and irregular contractile activity. The 
 3.3 - Results 
137 
 
peaks height was not uniform within the observed temporal window 
(Figure 12A, left panel). When the frequency was increased, the majority 
of the samples followed the pacing input with their own frequency. The 
power spectral density (PSD) of the signal assessed that the frequency 
is highly spread within the spectrum, indicating the partial inability of 
the constructs in following the pacing (Figure 12B, left panel). These 
data collectively suggest that, even if the constructs responded to the 
stimulation, the tissue maturation in terms of functional coupling of the 
cells was not yet achieved. 
At day 9, no spontaneous beating was observed neither in 
dynamically stimulated nor in static controls. Noteworthy, no statically 
cultured ECT resulted to be functionally mature. On the contrary, all 
the dynamically stimulated constructs responded to external pacing. ET 
and MCR resulted to be 3.6±0.8 V/cm and 5.2±1.46 Hz, respectively 
(Figure 11). The signals processed from the video analysis of the 
contractility during stimulation at 1Hz showed a synchronous and 
regular contractile activity of the 3D constructs. The peaks height was 
uniform within the observed temporal window (Figure 12A, right panel). 
The power spectral density (PSD) of the signal assessed that the 
dominant frequency is localized at 1 Hz, i.e. the pacing frequency, 
indicating the ability of the constructs in following the pacing (Figure 
12B, right panel,). When the frequency was increased, the samples were 
following the pacing input according to the correspondent frequency. In 
this case, the dynamic stimulation was instrumental for the further 
development of the excitation-contraction coupling machinery and so for 
tissue maturation. Indeed, as confirmed by the histologic images, even if 
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the network of cTnI-positive (or actinin-positive) cells was limited in 
thickness and confined to the lateral edge of the construct, it was 
continuous along the longitudinal cross section. Furthermore, the 
application of the cyclic mechanical stimulation increased also the Cx43 
expression which implies the presence of electrical gap junctions. 
 
Figure 11: Graphs displaying the excitation threshold and maximum 
capture rate at 5 and 9 days of static and dynamic conditions and after 5 or 9 
days of culture. 
 
Figure 12: Analysis of the contractility (A) and the dominant frequency 
(B) of ECTs under pacing after 5 days in static condition (left)or 5+4 days in 
dynamic culture (right)  
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3.3.5 Mechanical uniaxial test and collagen quantification  
The Young Modulus (E) was calculated by linear regression of the 
stress-strain curve in the range of 0-30% elongation. The ring shaped 
ECTs were hooked in the Microbionix (MTS System) using a 2N load 
cell (Figure 13, left panel). The modulus calculated in this range was 
found to be coherent with the elastic modulus calculated within the 
entire stress-strain curve range, till rupture (data not shown). This 
finding suggests that it is possible to assess the progress of the construct 
stiffness along the culture in a non-destructive manner within the 
established range of strain.  
Constructs were pre-tensioned with an initial load of 20mN and, after 
a series of 10 cycles of 0-10% strain at 0.1 Hz, were stretched until failure. 
Elastic modulus was found to only slightly increase (6.7%) in the first 
five days of culture: 29.6±8.9 KPa and 31.7±3.1 KPa at day 1 and 5, 
respectively (Figure 13, right panel). At day 9, E for static condition 
was found to be 87.5±9.2 KPa and increased by 194.9% compared to the 
beginning of the culture. After additional 4 days of culture in dynamic 
condition, E increased up to 117.3 ± 13.0 KPa (Figure 13, right panel). 
Therefore, dynamically stimulated samples further improved the 
mechanical properties, by 295.5% and 34.1%, compared to constructs 
statically cultured for 1 or 9 days, respectively. 
With respect to the beginning of the stimulation (at day 5), E of samples 
that underwent to cyclic stretch increased by 270.5% while the static 
controls had an increase of only 176.3% in further 4 days of culture. 
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Figure 13: Set-up of the mechanical test (left panel).Young Modulus (E) of 
the constructs found in static or dynamic conditions (right panel) 
The total content of collagen per sample was quantified via 
hydroxyproline assay and the total and was normalized by the respective 
amount of DNA. 
The collagen content was 0.38 ± 0.07 and 0.52 ± 0.33 at day 1 and 5, 
respectively (Figure 14, left panel). After 5 days of static culture, the 
collagen amount increased by 37.7%. At day 9, the collagen content arose 
to 1.76 ± 0.52 for static condition and was 2.85 ± 0.51 in the dynamic 
stimulated constructs (Figure 14, left panel). For constructs after 9 days 
of static culture, the collagen content increased by 366.8% compared 
with constructs at the first day of culture. The presence of collagen in 
the dynamic stimulated samples was further enhanced with an increase 
of 653.9% compared with constructs at the first day of culture. With 
respect to day 5, i.e. at the beginning of the stimulation, the collagen 
content of samples that underwent to cyclic stretch increased by 445.7% 
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while the static controls had an increase of 239.2% in further 4 days of 
culture.  
Both the Young modulus and the collagen content increased over the 
time in culture. Figure 14 (right panel) shows a plot of the collagen 
content versus E regardless to the culture condition. The linear 
regression calculated on the data (R2=0.90) showed a significant 
correlation indicating that the enhancement of the mechanical properties 
could be ascribed to the collagen deposited in the ECM along the culture. 
This is reasonable, as collagen is the primary load-bearing protein which 
provides passive stiffness during diastole in the native heart matrix. 
(Fomovsky, Thomopoulos and Holmes 2010). 
Interestingly, in the dynamic condition the 61.5% more of collagen 
content was found in comparison with the static control. The increment 
of collagen is most likely due to the superior presence of fibroblasts in 
the dynamic condition compared to the static controls and that, 
somehow, the cyclic stretch likely enhanced the proliferation of 
fibroblasts and consequently the amount of the produced ECM.  
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Figure 14: Collagen content normalized to DNA (left panel) and linear 
regression of the collagen content versus Young modulus (right panel). 
3.4 Discussions and Conclusions 
Individually, both mechanical and electrical stimulation have been 
established as standard conditioning methods for engineered cardiac 
constructs and have been studied extensively. These stimuli were shown 
to significantly increase the functional and the overall maturation of the 
cardiac-like tissues. While electrical stimulation is related to the 
establishment of functional gap junction, mechanical stimulation was 
shown to particularly improve the 3D tissue organization, cell alignment, 
cardiac maturation and the functionality in terms of generated active 
force. Mechanical stimulation alone appears quite a potent regulator in 
the development and cardiac morphogenesis, indeed much of the 
reorganization that occurs in utero is in the presence of changing 
mechanical stimuli (Stoppel, Kaplan and Black 2016). 
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There are different types of mechanical stimulation that can be 
applied, static or cyclic loading (corresponding to isometric and isotonic 
contraction) or auxotonic loading (a combination of isometric and 
isotonic loading). Even if auxotonic loading seems to resemble the 
physiologic contraction cycle quite closely, cyclic strain could be applied 
also in early maturation stage of the cardiac constructs. Indeed, under a 
proper frequency, the engineered constructs could adapts the contraction 
cycle to the stretch cycle (W. Zimmermann, 2013). Auxotonic 
contraction indeed are possible only when the myofibers are quite mature 
and the contractile unit is well formed and is able to contracts.  
Several bioreactors have been developed to provide controlled 
mechanical stimulation during culture (Akhyari, et al. 2002 , Birla, 
Huang and Dennis 2007, Morgan and Black III 2014, Salazar, et al. 2015) 
to generate reliable functional cardiac in vitro models to investigate 
fundamental biological questions. However, most of the past bioreactors 
focused on the mere application of the cyclic strain. Based on our 
knowledge, there is not yet a device capable to apply physiological strain 
to 3D mm-thick samples: (1) mimicking the wide range of conditions 
experienced by the heart tissue in vivo, (2) monitoring the maturation 
progresses and (3) adapting the stimulation pattern to the actual 
maturation stage of the constructs. 
In this PhD project, the aim was to develop a new bioreactor-based 
platform which, in its most advanced operational mode, is capable to 
deliver native-like/pathologic stimuli, measuring in real-time the tissue 
response (and the milieu parameters) and eventually adapting the 
stimulation to the maturation phase of the constructs. As a proof of 
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concept and towards the final validation of the platform potential, in 
this first experimental series, the bioreactor has been used in its basic 
configuration, to verify its feasibility in delivering mechanical cyclical 
stimulation to 3D fibrin-based, ring shaped Engineered Cardiac Tissue 
(ECTs) under dynamic culture.  
Firstly, the platform has been verified for the engineering design and 
the suitability in culturing ad-hoc designed constructs. Indeed, the 
bioreactor showed: (i) ease and quickness of assembling the device 
components as well as loading the constructs, (ii) maintenance of the 
culture sterility during dynamic motion (iii) capability in setting the 
culture parameters (cyclic displacement and frequency) by means of the 
software user interface, (iv) preservation of the mechanical functionality 
and long-term performances. 
Secondly, the effects of mechanical conditioning on ECTs have been 
evaluated. To that end, neonatal rat cardiomyocytes were embedded in 
a fibrin gel and the generated constructs were pre-cultured for 5 days in 
static condition and transferred into the bioreactor to be cyclically 
stretched for 4 days (10% strain at 1 Hz). In parallel, control engineered 
ring-tissues were cultured statically for 9 days. 
To fulfil this purpose, the fibrin gel composition and fibrin to 
thrombin ratio where chosen to integrate some requirements: (1) ease of 
casting, (2) manageability, and (3) adequate hardiness for mechanical 
loading as well as the control of degradation. Several combinations and 
proportions of the components of the fibrin gel mixture (i.e. mainly 
calcium, fibrinogen, thrombin and cells), for heart tissue models, are 
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proposed in literature mostly to adjust the time of polymerization and 
degradation reactions, also controlled by using protease inhibitors, such 
as aprotinin and tranexamic acid (Cholewinski, et al. 2009, Birla, Huang 
and Dennis 2007, Morgan and Black III 2014). Besides, the ECTs mix 
composition, must be adapted and optimized for the specific 
shape/topology, casting method and the experiment settings of each 
culture platform. (Yuan, Sullivan and Black 2011). 
According to this, the fibrin gel mixture and the casting technique 
chosen in this work allowed for a fast polymerisation and gel compaction 
as well as repeatability in the ECTs topology. The use of tAMCA, 
supplemented in the culture medium, allowed to control the degradation 
within the 5 days of pre-culture before the mechanical stimulation 
started. Furthermore, histologic H&E representative images of the 
samples at day 1, showed a homogenous cell distribution within the 
entire scaffold confirming the suitability of the casting protocol.  
The use of the bioreactor platform showed to be instrumental for 
delivering sinusoidal cyclic strain, resulting in ECT maturation and in 
the formation of electrical gap junctional protein between neighboring 
cardiomyocytes. Fluorescent and confocal images of the stimulated 
construct showed a network of cTnI positive or sarcomeric α-actinin, 
longitudinally oriented, elongated and mature cardiomyocytes 
prevalently localized on the lateral edge of the construct, ranging within 
a thickness of 30µm up to 100 µm and continuous along the longitudinal 
cross section. Stimulation increased also the Cx43 expression mostly on 
lateral parts of the cell membrane. Conversely, such structures were 
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sporadically found in the static controls. Prevalently isolated, not 
connected and immature cells were found at edge as well as in the centre 
of the constructs. These findings were consistent with previous studies 
on neonatal rat or chick cardiomyocytes embedded in Matrigel and 
collagen I, subjected to mechanical stimulation (10% strain, 2Hz) 
(Zimmermann, Schneiderbanger, et al. 2002). These structural properties 
were associated to an increased contraction force as well as a positive 
force-length and negative force frequency relationship (Zimmermann, 
Fink, et al. 2000, Fink, et al. 2000 ). 
Although nuclei appeared to be homogenously distributed through 
the sample thickness, this kind of structure was systematically found at 
the edges and specifically only on one side of the longitudinal cross 
section. Limitation of the oxygen (and nutrients) diffusion, within the 
three-dimensional constructs, has been already observed in previous 
studies: increasing the distance from the construct edge correlated with 
a decline in cardiomyocyte density and viability towards the centre. 
(Seiffert, et al. 2013). In the 5 days of pre-culture, constructs were 
statically housed within six-well plate and supplemented with 5mL of 
culture medium. In this set-up, nutrient transport is diffusion-limited 
and one side of the ring is in direct contact with the culture plate and 
less exposed to the medium. Indeed, images of the central transverse 
section, showed higher cellularity and the presence of the network almost 
all around the section with the exception of a small portion. This pre-
culture condition could justify why, after stimulation, in the longitudinal 
cross sections, for the majority of the samples, this more optimal 
organization was observed only on one side of the longitudinal cross 
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section. This part most likely corresponded to the portion of the ring 
that was in contact with either the well plate in static condition or the 
other replicates during cyclic strain and, therefore, resulted less exposed 
to the culture medium. Furthermore, even if the applied stretch could 
promote nutrient and waste exchange by cyclically opening the scaffold 
structure, based on our results, the diffusion of nutrients and oxygen 
appeared not to be efficient in the very centre of the ring.  
The improved functional structure, promoted by the mechanical 
stimulation, was confirmed by the contractility assessment. Before 
stimulation, after 5 days of static pre-culture, ECTs responded to the 
pacing (ET=7.2±3.3 V/cm and MCR=5.0±2.1 Hz) irregularly and 
following the increasing pacing input with their own frequency. After 
cyclic stimulation they were beating synchronously at the pacing 
frequency with an excitation threshold mean value about the half 
(3.6±0.8 V/cm V/cm) and following the increase of pacing within a 
maximum capture rate range slightly higher (5.0±2.1 Hz). These 
electrical excitability parameters are usually used for evaluation of the 
electrical functionality in protocols where the sole electrical stimulation 
is applied, which is known to enhance the intercellular electrical 
communication (Radisic, Park and Shing, et al. 2004). In protocols where 
only the mechanical stimulation is administered, the functional 
performances, for spontaneous beating and in the presence of pacing, is 
assessed by measuring the force of contraction (twitch tension) (Salazar, 
et al. 2015). However, also the application of the sole mechanical 
stimulation resulted in an analogous functional coupling of cardiac cells 
(Zimmermann, et al. 2006), indicating that phasic stretch is instrumental 
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for the further development of an adult-like cardiac phenotype 
responsive to electrical excitation. 
The collagen content increased along the culture, and further 
increased in the presence of cyclic stretch; this is consistent with studies 
of cardiomyocytes cultured in 3D scaffolds composed by collagen I and 
Matrigel (Fink, et al. 2000 , Zimmermann, Schneiderbanger, et al. 2002) 
or fibrin (Salazar, et al. 2015). Also, the collagen content was found to 
be positively correlated with the Young modulus, which is reasonable 
since the role of collagen in sustaining the heart passive stiffness 
(Fomovsky, Thomopoulos and Holmes 2010). It is possible to speculate 
that the major amount of collagen found in the stimulated constructs 
was due to new ECM synthetized by fibroblasts (Salazar, et al. 2015). 
Indeed, a superior presence of fibroblasts was observed in the dynamic 
condition compared to the static controls. Some cells were double 
positive for vimentin and Ki67, which indicates that mechanical 
stimulation might support fibroblast proliferation. Further 
investigations are also needed in order to ascertain if any phenotype 
switch to myofibroblasts has occurred (Zimmermann, Schneiderbanger, 
et al. 2002).  
One of the main limitations emerged during operations with the 
current bioreactor design is the low number of replicates that could be 
stretched in each experiment and the fact that each replicate is not 
independent from the others. A novel attachment mechanism could be 
devised for increasing the number of cultured samples guaranteeing 
homogeneous load. Different geometries of the ECTs should be also 
tested. The ratio fibrinogen to thrombin can also be tuned to evaluate 
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the effect on oxygen diffusion within the inner part of the 3D construct. 
Assays to assess viability should also be performed. The use of special 
well plates that allow for an exchange of nutrients during static pre-
culture could optimize the tissue development since the early phase of 
pre-culture. 
In conclusion, this study has shown the feasibility of the bioreactor-
platform in delivering mechanical cyclical stimulation to 3D fibrin-based, 
ring shaped ECTs. The platform has been verified for the engineering 
design and the suitability in culturing the ad-hoc designed constructs. 
Jointly, compared with static controls, ECTs cultured under dynamic 
stimulation were functionally mature, capable to respond to external 
electrical pacing. ECTs also showed a significant matrix remodeling, 
followed by an increase of collagen deposition. The assessment of the 
mechanical properties at predefined step points of the culture revealed 
to be a fundamental tool to control cell phenotype and thus ECM 
synthesis.  
In this very first experiments, the bioreactor platform has been used 
in its basic configuration, disabling the force, pH and O2 sensing 
functions. Mechanical assessment of the fibrin based construct has been 
conducted with a standard test machine to separate the variability due 
to the device under investigation from the ECTs variability.  
In the next steps, to reach the comprehensive validation of the 
platform, the constructs properties and the milieu parameters will be 
monitored and recorded by the sensors (force, pH, O2), which have been 
already devised. The output from these experimental data will serve to 
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generate a dataset usable for creating a developmental predictive model 
in order to adequately (physiologically) train the cardiac construct to 
develop optimal contractile and structural properties.  
In a further step, the bioreactor potential could be exploited by using 
human Endothelial stem cells (ESC) or induced Pluripotent Stem Cells 
(iPSC) to possibly generate cardiac patches capable to substitute the 
damaged myocardium after a myocardial infarction. 
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Chapter 4  
Conclusions and Future Perspectives 
4.1 Bioreactor platform 
In this thesis the design and development of a bioreactor platform for 
culturing cardiac tissue has been presented. The here proposed system 
is designed (1) to deliver native-like or pathologic-like stimuli (namely 
cyclic strain) to 3D engineered cardiac constructs, (2) to assess their 
mechanical properties along the culture in a non-destructive manner and 
(3) to monitor in real time the culture environment. In the past years, 
several devices have been developed for the purpose of culturing cardiac 
tissue (Birla, Huang and Dennis 2007, Kensah, et al. 2011, Govoni, et 
al. 2014). However, the mechanical properties of the constructs have 
never been monitored in combination with physicochemical parameters 
(Kensah, et al. 2011). Moreover, the delivered mechanical stimulation 
have been mainly narrowed to pre-defined stimulation waveforms, thus 
limiting the application of biomimetic culture strategies (Birla, Huang 
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and Dennis 2007). For these main reasons, the bioreactor-based 
platforms developed for cardiac tissue engineering applications so far, 
are still ineffective in properly training the cardiac engineered muscle to 
develop optimal contractile and structural properties. (Zimmermann 
2013). 
The engineering solutions which have been introduced in the design 
of the bioreactor allowed the implementation of a displacement-
controlled strategy within a wide range of physiological/pathological 
elongations and frequencies. In principle, the designed control 
architecture is also suitable for a force-based control, when a force 
transducer is used in the control loop in place of the position transducer.  
In view of the advantages of using a linear actuator, which simplifies 
the actuation kinematics per-se, the application of the voice coil allowed 
the obtainment of an enhanced positioning accuracy and of markedly 
high accelerations. Indeed, one of the main drawback of using stepper 
motors is their limited bandwidth, which would prevent the exploration 
of high cycle rates in experiments, a problem that can be addressed only 
by accepting an impaired mechanical displacement resolution (Salazar, 
et al. 2015).  
Thanks to the adopted control strategy, high fidelity tracking of the 
reference position is guaranteed also when modification of environmental 
variables (e.g. temperature, humidity, and pressure) can be the source 
of unexpected additional friction. 
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With regards to the sensing unit, the selected sensors for O2 and pH 
monitoring are characterized by the proper sensitivity. Moreover, when 
embedded within the culture unit, the housing mechanism (bayonet 
fitting inserts) and the sterilization procedures have given evidence of 
sterility maintenance both in static and dynamic working conditions.  
The sensing unit, i.e. the load cell, has demonstrated the capability 
to estimate the mechanical properties, i.e. stiffness, of a calibrated 
instrumentation spring within maximum 10% of the real value, thus 
confirming that the system can be applied for a real time evaluation of 
the mechanical properties of cultured constructs, even if further 
improvements are required to increase its reliability, when applied to 
monitor real constructs. 
Finally, the software user-interface, which have been developed on-
purpose, has demonstrated to fulfill the design requisites in terms of (i) 
driving the stimulation settings and (ii) displaying signals from the 
sensor. 
4.2 Engineered Cardiac Tissues 
As a proof of concept, and towards the final validation of the platform 
potential, a first experimental campaign has been carried out with a 
double aim: (1) to verify the bioreactor feasibility in delivering 
mechanical cyclical stimulation to 3D fibrin-based, ring shaped 
Engineered Cardiac Tissues (ECTs); (2) to assess the effect of cyclic 
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strain on tissue maturation, contractility and modification on its elastic 
properties. 
To that end, neonatal rat cardiomyocytes embedded in ring-shaped 
fibrin gel, have been pre-cultured for 5 days in static condition and 
transferred into the bioreactor to be cyclically stretched for 4 days (10% 
strain at 1 Hz). In parallel, control engineered ring-tissues have been 
cultured statically for 9 days.  
Concerning the first aim, the reliability of the bioreactor platform has 
been verified both for the engineering design and for the capability of 
culturing ad-hoc designed constructs. 
With regard to the second aim, the sinusoidal cyclic strain prescribed 
to the construct has showed to be instrumental in ECTs maturation and 
in the formation of electrical gap junctional proteins among neighboring 
cardiomyocytes. Fluorescent and confocal microscopy images have 
confirmed that the imposed stimulation has promoted: (1) the Cx43 
expression and (2) the formation of a network of cTnI/sarcomeric α-
actinin positive, longitudinally oriented, elongated and mature 
cardiomyocytes along the longitudinal cross section (even if prevalently 
localized on lateral edge) of the construct. Conversely, in the static 
controls, prevalently isolated, not connected and immature cells have 
been observed at edge as well as in the centre of the constructs.  
The mechanical stimulation was also instrumental to promote the 
development of an adult-like cardiac phenotype responsive to electrical 
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excitation. The mechanical stimulation has improved the functional 
coupling of the cells: while static controls have been observed to not beat 
neither spontaneously nor under pacing, stimulated constructs have 
responded regularly and synchronously to pacing. 
Among the main findings, ECTs have been observed to undergo a 
significant matrix remodelling, followed by an increase of collagen 
deposition. Moreover it has been found that the cyclic stimulation 
enhanced the mechanical properties of the cultured ring constructs. In 
particular a marked increase of the Young modulus has been observed 
for dynamically stimulated specimen, compared to the first day of 
culture and the static controls. The construct increased Young modulus 
has been found to be correlated with the increase of collagen, which is 
the primary load-bearing protein in the native heart matrix. 
4.3 Limitations 
The current bioreactor configuration could be further optimized to 
improve even more the control over the mechanical stimulation and 
therefore over the final quality of the engineered cardiac models. 
From a mechanical point of view, the solution adopted to couple the 
actuator and the engineered tissue (i.e., the load) might introduce 
unexpected friction that affects the displacement accuracy. Indeed, as 
far as the test conditions are significantly changing (e.g. humidity, 
increase of temperature, thermal dilatation of the components) the 
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friction mitigation sustained by the feed-forward loop (off-line 
characterized), becomes inadequate. 
A few structural modifications, involving the increase of the gap 
between sliding elements, i.e. the lateral walls and the shafts, or the 
design of an alternative coupling method, could actually mitigate the 
friction effects.  
Pertaining to the control strategy, the hardware used to implement 
the control strategy presents few limitations. During high speed 
displacements, processor frequency could be not high enough to close the 
actuation displacement loop. A future solution could be to separate the 
monitoring of the sensors (which have a slower dynamic) from the 
actuation control, by using two dedicated modules in order to guarantee 
a Hard Real Time (HRT) performance. 
Furthermore, the coupling between the load cell and the shaft on the 
“sensing side”, has revealed to be a possible design weakness. In the 
current set-up the load cell is placed outside of the culture chamber, and 
the force exerted by the construct has to be transmitted through the 
lateral wall. This architectural solution could be a source of inaccuracy. 
Future modifications could embed the housing of the force sensor within 
the culture chamber in order to increase the measurement reliability. 
About the feasibility in culturing engineering cardiac models, the 
main limitation of the current bioreactor design is in the low number of 
replicates that could be stretched in each experiment and the fact that 
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each replicate is not independent from the others. A novel attachment 
mechanism could be devised for increasing the number of cultured 
samples guaranteeing homogeneous load.  
Concerning the engineered cardiac tissues, other geometries besides 
the ring-shaped samples (e.g. strips, dog bone-shape) could be used in 
order to simplify the casting procedure and to perform the mechanical 
testing according to standard protocol. Moreover, the integration of well 
plates allowing for an exchange of nutrients during static pre-culture 
could improve the protocol and optimize the maturation of the tissue 
since the early phase of pre-culture. 
4.4 Conclusive Considerations and Future works 
The biological validation of the platform here proposed has been 
planned in a step-by-step manner. This first biological experimental 
series allowed to verify the capability of the bioreactor of delivering 
mechanical stimulation to 3D fibrin-based, ring shaped ECTs and 
showed that the application of  cyclic strain (10%, 1Hz) improved tissue 
maturation, contractility and stiffness.  
In these experiments, the bioreactor platform has been used in its 
basic configuration, disabling the force, pH and O2 sensing functions. 
Mechanical assessment of the fibrin based construct has been conducted 
with a standard test machine (MTS, MTS System Corporation, USA) 
to separate the variability due to the device under investigation from 
the ECTs variability.  
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Two further steps are required in order to reach a comprehensive 
validation of the platform. In the next step, biological tests will be 
carried out applying cyclic strain while monitoring in real time the 
evolution of the mechanical properties by enabling the force measuring 
system of the bioreactor. Besides, the O2 and pH milieu parameters, will 
be monitored and recorded. The output from these experimental data 
will serve as a basis for the generation of a dataset to be used as 
predictive model to mimic the developmental process.  
Thanks to the adopted hardware and software architecture the 
further step will be the implementation of an adaptive culture strategy. 
Indeed, the use of an automated feedback loop could allow to measure, 
in real-time, the tissue mechanical response and, on its basis, to define 
the appropriate mechanical stimulation in order to adequately 
(physiologically) stimulate the cardiac construct to develop optimal 
contractile and structural properties.  
Furthermore, the integration of an electrical stimulation system to 
facilitate syncytial arrangement of cardiomyocyte and further assist 
morphologic and functional maturation, can be easily integrated within 
the bioreactor platform to enrich its functionalities. 
Finally, the implementation of an automated feeding perfusion circuit 
will allow the automatic exchange of the medium within the culture 
chamber, in response to significant variations of the metabolic quantities 
measured by the milieu sensors. 
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